implant practice us - january/february 2014 issue - vol7.1

FI

LL

T

HE

D

EF

EC

T.

TH

E

EN

TI

RE

D

EF

EC

T!

Learn how to easily prevent particle migration using expandable

NuOss® XC Socket and NuOss® XC Sinus.

For details see page 49

White Box covering the

left side bleed should be removed.

PAYING SUBSCRIBERS EARN 24 CONTINUING EDUCATION CREDITS PER YEAR!

clinical articles • management advice • practice profiles • technology reviews

January/February 2014 – Vol 7 No 1

P R O M O T I N G E X C E L L E N C E I N I M P L A N T O L O G Y

Verified osteoinductive allograft putty for dental

implant regenerationDr. John Lupovici

Practice profileDr. Louis Kaufman

Corporate profileDIO

Tackling a challenging esthetic clinical situationDr. Cary A. Shapoff

Multi-disciplinary approach to the treatment of traumatic root fracture

Drs. Peter Fairbairn andSharon Stern

A chemotherapy patient’s experience with dental implantsDr. Bryan R. Krey andDr. Richard G. Dong

PLAN

SCAN

PLACE

RESTORE

WHEN THE OSTEOTOMY MUST BE NARROW -SO MUST YOUR IMPLANT CHOICE

Choose the LOCATOR® Overdenture Implant SystemIt’s a fact – denture patients commonly have narrow ridges and will require bone grafting before standard implants can be placed. Manyof these patients will decline grafting due to the additional treatment time or cost. For these patients, the new narrow diameter LOCATOR Overdenture Implant (LODI) System may be the perfect fi t. Make LODI your new go-to implant for overdenture patients with narrow ridges or limited fi nances and stop turning away patients who decline grafting. Your referrals will love that LODI features all the benefi ts of the LOCATOR Attachment system that they prefer, and that all of the restorative components are included.

©2013 ZEST Anchors LLC. All rights reserved. ZEST and LOCATOR are registeredtrademarks of ZEST IP Holdings, LLC.

2.5mm

2.4mm

4mm

2.9mm

included with each Implant

Discover the benefi ts that LODI can bring to your practice today by visiting www.zestanchors.com/LODI/31 or calling 855.868.LODI (5634).

Cuff Heights

Diameters

Volume 7 Number 1 Implant practice 1

January/February 2014 - Volume 7 Number 1

EDITORIAL ADVISORSSteve Barter BDS, MSurgDent RCS Anthony Bendkowski BDS, LDS RCS, MFGDP, DipDSed, DPDS, MsurgDent Philip Bennett BDS, LDS RCS, FICOI Stephen Byfield BDS, MFGDP, FICD Sanjay Chopra BDS Andrew Dawood BDS, MSc, MRD RCS Professor Nikolaos Donos DDS, MS, PhD Abid Faqir BDS, MFDS RCS, MSc (MedSci) Koray Feran BDS, MSC, LDS RCS, FDS RCS Philip Freiburger BDS, MFGDP (UK) Jeffrey Ganeles, DMD, FACD Mark Hamburger BDS, BChD Mark Haswell BDS, MSc Gareth Jenkins BDS, FDS RCS, MScD Stephen Jones BDS, MSc, MGDS RCS, MRD RCS Gregori M. Kurtzman, DDS Jonathan Lack DDS, CertPerio, FCDS Samuel Lee, DDS David Little DDS Andrew Moore BDS, Dip Imp Dent RCS Ara Nazarian DDS Ken Nicholson BDS, MSc Michael R. Norton BDS, FDS RCS(ed) Rob Oretti BDS, MGDS RCS Christopher Orr BDS, BSc Fazeela Khan-Osborne BDS, LDS RCS, BSc, MSc Jay B. Reznick DMD, MD Nigel Saynor BDS Malcolm Schaller BDS Ashok Sethi BDS, DGDP, MGDS RCS, DUI Harry Shiers BDS, MSc, MGDS, MFDS Harris Sidelsky BDS, LDS RCS, MSc Paul Tipton BDS, MSc, DGDP(UK) Clive Waterman BDS, MDc, DGDP (UK) Peter Young BDS, PhD Brian T. Young DDS, MS

CE QUALITY ASSURANCE ADVISORY BOARDDr. Alexandra Day BDS, VTJulian English BA (Hons), editorial director FMCDr. Paul Langmaid CBE, BDS, ex chief dental officer to the Government

for WalesDr. Ellis Paul BDS, LDS, FFGDP (UK), FICD, editor-in-chief Private

DentistryDr. Chris Potts BDS, DGDP (UK), business advisor and ex-head of

Boots Dental, BUPA Dentalcover, VirginDr. Harry Shiers BDS, MSc (implant surgery), MGDS, MFDS, Harley St

referral implant surgeon

PUBLISHER | Lisa MolerEmail: [email protected] Tel: (480) 403-1505

MANAGING EDITOR | Mali Schantz-Feld Email: [email protected] Tel: (727) 515-5118

ASSISTANT EDITOR | Elizabeth RomanekEmail: [email protected] Tel: (727) 560-0255 EDITORIAL ASSISTANT | Mandi GrossEmail: [email protected] Tel: (727) 393-3394 DIRECTOR OF SALES | Michelle Manning Email: [email protected] Tel: (480) 621-8955

NATIONAL SALES/MARKETING MANAGER Drew Thornley Email: [email protected] Tel: (619) 459-9595

PRODUCTION MANAGER/CLIENT RELATIONS Adrienne Good Email: [email protected] Tel: (623) 340-4373 PRODUCTION ASST./SUBSCRIPTION COORD. Jacqueline Baker Email: [email protected] Tel: (480) 621-8955

MedMark, LLC15720 N. Greenway-Hayden Loop #9Scottsdale, AZ 85260Tel: (480) 621-8955 Fax: (480) 629-4002Toll-free: (866) 579-9496 Web: www.implantpracticeus.com

SUBSCRIPTION RATES1 year (6 issues) $99 3 years (18 issues) $239

© FMC 2013. All rights reserved. FMC is part of the specialist publishing group Springer

Science+Business Media. The publisher’s written consent must be obtained before any part of this publication may be reproduced in any form whatsoever, including photocopies and information retrieval systems. While every care has been taken in the preparation of this magazine, the publisher cannot be held responsible for the accuracy of the information printed herein, or in any consequence arising from it. The views expressed herein are those of the author(s) and not necessarily the opinion of either Implant Practice or the publisher.

When I think about advancements in implant dentistry that have most influenced my practice, I think about three things: 3D imaging, sinus grafting techniques,

and guided bone regeneration (GBR) procedures. When I opened my practice 11 years ago, I was trying to decide if I should implement digital imaging or continue with film. Today, I have a three-dimensional image of my patient’s maxilla and mandible before I’ve even introduced myself. It has provided us with the ability to accurately know the position of nerves, sinuses, and that sneaky osseous defect that can be lingering buccal to our osteotomy. Because of this information, flap designs have become minimally invasive and far less painful for our patients. Case acceptance has increased, providing patients a more thorough understanding of their treatment. 3D imaging has made the next advancement, sinus grafting, so predictable that we now even can see the exact thickness of the wall we need to drill through to access the sinus. Sinus grafting itself hasn’t changed. It is still a surgical procedure aiming to increase the amount of bone in the posterior maxilla by sacrificing the volume of the maxillary sinus. Thus, increasing our ability to place dental implants using fixed restorations on more patients. Although the outcome is the same, the methods have changed drastically. The Piezosurgery® unit allows us to cut bone without harming soft tissue. We can now predictably free up the Schneiderian membrane. There are drill kits akin to those used in neurosurgery, developed to allow surgeons to cut through the skull without harming the underlying dura mater. This same technology is now in place with the direct sinus procedure. Similar drills are used in order to avoid perforating the membrane of the sinus. When evaluating bone grafting techniques, the criteria must be predictability and ease of use. I find it fascinating that cow bone, which has been popular for ages, is now mixed within a collagen matrix to allow for precise placement, minimal migration, and enhanced bone growth at the site. The same Piezo unit spoken about with sinus grafting can be used for minimal heating of bone for a sagittal split with ridge-splitting techniques. This technique, when used in the right situation, can result in some of the most predictable gain in bone volume. The highly porous collagen structure allows for quicker turnover to bone via a highly formulated matrix. You can actually put bone where you want it; it stays, and it grows. There are now bone grafts used that have signals to form bone — bone morphogenic protein (BMP) — calling in stem cells to allow for quicker, more predictable bone formation. My practice has always been focused on patient comfort, and these advancements in 3D imaging have allowed for the most minimally invasive flap procedures, the most predictable bone placement, and in turn, significantly decreased pain and down time for my patients.

Ryan Taylor, DDS, MS

Dr. Taylor established his practice in Periodontics and Implant Dentistry in Sarasota, Florida, in 2004. He is an active member in the American Academy of Periodontology, American Academy of Implant Dentistry, the Academy of Osseointegration, and the Academy of Oral Implantology. He is also a

member of the American Dental Association, Florida Dental Association, West Coast District Dental Association, and Sarasota County Dental Association.

INT

RO

DU

CT

ION

New technologies in the advancement of implant dentistry

TABLE OF CONTENTS

Practice profile 6Dr. Louis Kaufman: Continuing a legacyThis clinician is driven by inspiration, a great team, and desire for knowledge.

2 Implant practice Volume 7 Number 1

Case studyTackling a challenging esthetic

clinical situation

Dr. Cary A. Shapoff illustrates a case

replacing two adjacent maxillary

central incisors ..........................14

Patient insightA chemotherapy patient’s

experience with dental implants

Dr. Bryan R. Krey and retired

engineer Dr. Richard G. Dong join

forces to facilitate implant placement

during cancer treatment ............18

Corporate profile 9DIO CorporationPromoting happiness and healthy lifestyles

ON THE COVER

Cover photo courtesy of Dr. John Lupovici. Article begins on page 42.

TABLE OF CONTENTS


Continuing educationMulti-disciplinary approach to

the treatment of traumatic root

fracture: a case study

Drs. Peter Fairbairn and Sharon Stern

present a multi-disciplinary approach

to tackling a tricky trauma case ....25

Management of biological

and biomechanical implant

complications

Drs. Yung-Ting Hsu and Hom-

Lay Wang summarize and reveal

management protocols for implant

complications ..............................32

Advanced technologies38

TechnologyAdvanced technologies and

materials to efficiently deliver full

mouth reconstructions

Dr. Ara Nazarian suggests a treatment

solution that results in more control

and fewer appointments ..............38

Verified osteoinductive allograft

putty for dental implant

regeneration: preliminary findings

of three clinical applications

Dr. John Lupovici illustrates clinical

cases using RegenerOss® Allograft

Putty to regenerate three distinct

osseous defects ..........................42

Product profileNuOss® XC bone grafting

composite .................................49

On the horizonI want my teeth yesterday!

Dr. Justin Moody discusses a time-

saving technology in a fast-paced

world ............................................50

Materials & equipment ....................54

Diary ....................................56

Discover ATLANTIS™ ISUSPatient satisfaction meets clinical benefi ts

In addition to ATLANTIS™ patient-specifi c abutments, the ATLANTIS™ ISUS solution includes a full range of implant suprastructures for partial- and full-arch restorations. The range of standard and custom bars, bridges and hybrids allows for fl exibility in supporting fi xed and removable dental prostheses.

For more information, including a complete implant compatibility list, visit www.dentsplyimplants.com.

7969

0-U

S-13

07 ©

201

3 D

ENTS

PLY

Inte

rnat

iona

l, In

c.

• Available for all major implant systems

• Precise, tension-free fi t

• Comprehensive 10-year warranty

Now available!

79690-US-1307 ATLANTIS ISUS Implant Practice.indd 1 10/24/2013 4:58:52 PM

What can you tell us about your background? I was born into a dental family. I graduated from the University of Illinois College of Dentistry, and in 1995, joined my father Richard’s well-established 50-year-old general dentistry practice treating third- and fourth-generation patients. Besides my clinical experience, I have a diverse business background. I earned an MBA from the Computer Science Executive Management Program at DePaul University and a BA in Marketing and Economics from Kendall College in Evanston, Illinois. Prior to attending dental school, I worked in management at Pillsbury Corporation as a specialist in point-of-service site development and restaurant management for 5 years. The skill set that I developed in corporate management has helped me grow my Hyde Park (Chicago) private practice into a multimillion dollar business focused on comprehensive oral healthcare and cosmetic smile design. I serve on the advisory board of numerous dental manufacturers, consult on product development, and am honored to educate clinicians around the globe at approximately 20 continuing education programs annually. I also have published numerous articles focused on restorative and cosmetic dentistry.

Is your practice limited to implants?No.

Why did you decide to focus on implantology? I have been restoring implants since graduating dental school.

How long have you been practicing, and what systems do you use?Biomet 3i™, Noble Biocare®, BioHorizons®, Astra Tech Implant System™, and Straumann®.

What training have you undertaken? I have taken numerous courses on

restoring and treatment planning implants, and recently completed my training in the surgical placement of implants.

What is the most satisfying aspect of your practice?The greatest satisfaction is giving patients back the ability to function and re-create their smile.

Professionally, what are you most proud of?I am proud of how as a profession we stand together on so many fronts. We have dentists who lobby and legislate for those on the front lines providing care to patients. There is a “we” mentality versus an “I” mentality. I couldn’t imagine a better career. Coming from corporate America years ago, to being a true entrepreneur with guidance and backing all around is incredible.

What do you think is unique about your practice?Without a doubt, it’s location. If you have never been to Hyde Park (a neighborhood in Chicago), then it’s worth the trip. It is a microcosm of the world. So many nationalities and economic strata exist. Another unique aspect is that we have been a part of the community for 60-plus years. We provide care to fifth-generation patients.

What has been your biggest challenge?The biggest challenge right now is space. I am in an old building, and our suites are not designed for sit-down dentistry. I ask myself how my dad did it for so long. At the present time, I am 2½ years out for my lease. I am getting quotes on gutting the existing space or moving to a different floor so we can continue to operate until it’s time to move. Having stayed on top of technology, I am finding we are running out of space.

What would you have become if you had not become a dentist?Great question. I would have wanted to become a thoracic surgeon but did not

Dr. Louis Kaufman


PRACTICE PROFILE

Continuing a legacy

Who has inspired you? I believe inspiration comes

from within or the desire to

learn and do more. I am lucky

my father was a practicing

dentist for more than 60

years. He always stayed up

to date on techniques and

procedures. I was fortunate

to have a strong role model.

The dental community has

many amazing specialists

and general dentists whom

I learn from by reading and

reviewing journals.

infinity Dental Implant Systems manufactured by ACE Surgical Supply Co., Inc. © Copyright 2014

SURGICAL SUPPLY CO., INC.

GIVING YOU THE FAMILIARITY AND CONFIDENCE YOU NEED WITH EVERY PLACEMENT.

• Resorbable Blast Media Surface• Secure Connecting Platform• Long Lasting Precision Surgical Drills• Lifetime Warranty

INTERNAL HEXTRI-CAM

The infinity TRI-CAM and INTERNAL HEX Implant Systems have been designed to be compatible with the other leading tri-channel and internal hexagon implant systems you already know. Infinity implants and prosthetics offer familiar options and superior quality, without the inflated costs—just $149.99 including cover screw. To learn more about infinity Implant Systems from ACE Surgical, visit our website: www.acesurgical.com

or call us: 800.441.3100.


PRACTICE PROFILE

want to be finishing up in my forties. I already changed careers to go into either medicine or dentistry. After my research of both, I decided on the dental career path because at age 27 I would not have finished a medical-surgical path until around 40 years old.

What is the future of implants and dentistry?The future of implants in dentistry is continually growing. We have so many dentists who are not restoring or placing implants. My goal this year was to take an implant surgical course to place implants, and I will only do the straightforward cases. Everything else goes to the oral surgeon or periodontist. I strongly believe that the use of surgical guides will become the standard of care in the placement of the implant.

What are your top tips for main-taining a successful practice?The key ingredient is to be engaged and to surround myself with a great team of people. We have to continually motivate, educate, and appreciate our team members. I am a big believer in educating my team. I try to teach something new to as many people as possible. I try to learn something new from somebody every day. The other key is to make sure you give your

patients the time they deserve. Become interested in them as people. There are so many pearls. The bottom line is that we are in a “people business,” and we have to have a team that works great with the public. Also, don’t be afraid to fire a team member that just won’t perform to the levels that the business demands.

What advice would you give to budding implantologists?Take lots of continuing-education courses. Get educated on the restorative side and the surgical side of implants. Treatment planning from the functional restorative side is key for long-term success.

What are your hobbies, and what do you do in your spare time? I like to spend my spare time with my teenage kids. It’s not a lot of time, but I take what I can get. I like to read fiction and enjoy going to the movies. I recently rescued a dog, and we take a lot of walks. I go to the gym regularly. Our profession is physically and mentally demanding, so I have become a big believer in eating right and being on a fitness program. I also like taking my bike out for rides. The rest of my time is spent preparing for upcoming lectures that I am presenting.

Dr. Kaufman’s team

Dr. Kaufman’s dog, Max

Dr. Kaufman with his children, Rachel and Jacob

Top Ten Favorites1. Planmeca ProMax® 3D — the

coolest piece of technology. I am constantly learning with this technology.

2. The technology called NuCalm™. Everybody should have it.

3. Chocolate Chip Banana Blizzard from Dairy Queen.

4. Must have music playing in the office. I am old school rock-and-roll with some of the new.

5. I like to try new restaurants.6. Deep-fried Oreos with vanilla ice

cream. If I go to Las Vegas, I go to Lava to have this. So much for nutrition.

7. I like new clothes and should not go into Nordstrom.

8. Taking my daughter clothes shopping. I get time to talk to her.

9. I love the game of basketball. Going to see the Chicago Bulls play is one of my greatest sources of entertainment. I understand the game but could never play it well.

10. I like pretending I have a bad cold/cough at the movie theater so nobody will sit in front of me, and I can put my feet up. :-)

IP


CO

RP

OR

AT

E P

RO

FILE

About the company

DIO Corporation

Volume 7 Number 1

CORPORATE PROFILE

Promoting happiness and healthy lifestyles

We at DIO Corporation (Kosdaq:039840) are dedicated to promoting happiness and healthy lifestyles in over 70 countries around the world with investment in and develop-ment of state-of-the-art dental implant technologies and advanced digital dental solutions. To further enhance our efforts, the DIO Implant Academy was established to provide both practical and advanced dental educa-tion to our partner clinicians globally. DIO also organizes annual educational symposia that serves as a way for our partner clinicians to meet, exchange knowledge and collabo-rate with renowned scholars and practitioners in the dental implant field. is in a strategic partnership with Dentsply

International (NASDAQ: XRAY) by virtue of Dentsply being DIO’s largest shareholder. Dentsply is one of the largest global dental products companies in the world.

• So called “Premium” Implants → “Affordable, Value-Added” Implants • Traditional “Analog” Dentistry → “Digital Dental Solutions”

DIO has long term staying power. DIO

DIO will lead the “Paradigm Shift in Dental Implants”


CORPORATE PROFILE

Volume 7 Number 1 Implant practice X

DIO Symposium at Las Vegas

CO

RP

OR

AT

E P

RO

FILE

“Paradigm Shift in Implant Dentistry” will be held on May 10 - 11th, 2014 at the Mandalay Bay Resort and Casino.

DIO Symposium Las Vegas 2014 will be an informative and educational event that will be a landmark event for our Company; and one that will not be forgotten.

We chose to organize our 2014 symposium in Las Vegas, which is an international destination for world-class entertainment, ultracool nightlife, renowned restaurants and luxury shopping venues. Furthermore, stunning hotels have raised the bar for service and entertain-ment. Amazing venues showcase world-class entertainers, whether they’re on the latest leg of a world tour or they’re must-see Las Vegas staples. The city is also home to some of the world’s best magicians, singers, impressionists, comedians and tribute acts.

PRADIGM SHIFT IN IMPLANT DENTISTRY

“Premium” Implants to “Affordable, Value Added” ImplantsTraditional “Analog” Dentistry to “Digital Dental Solutions”

PARADIGM SHIFT IN IMPLANT DENTISTRY


CORPORATE PROFILE

DIO Implant offers a full line up of implant designs and options to perfect your implant procedure under any situation with predictable and optimal results.UF, SM, Protem, Extrawide, FSN/FTNDIO holds best in class design, superior surfaces, state-of-the-art manufacturing, highest quality tools, drills and kits along with easy to learn protocols.

X Implant practice Volume 7 Number 1

CORPORATE PROFILE

DIO ImplantRenowned dental implants in over 70 countries

BEST IN CLASS MANUFACTURING

DIO Implant holds ISO 13485 certification

ISO 13485 is an International Organization for Standardiza-tion (ISO) standard that represents the requirements for a comprehensive quality management system for the design

and manufacture of medical devices.

UNIVERSAL FIXTUREUF

SUBMERGED SM

UNIVERSAL FIXTURE

CO

RP

OR

AT

E P

RO

FILE


DIO Digital Solutions

This information was provided by DIO.

• DIO Digital Solutions “Trione” brand lineup is composed of the “tried and true” best products and technologies globally.• Includes the most advanced intra-oral scanners, CAD applications & software and precision milling technologies.• DIO has developed highly advanced implant-oriented integrated digital applications and solutions designed for leading dental clinics and laboratories.• DIO is leading the “Paradigm Shift” from Analog to Digital Dentistry


Trios Scan

Milling (Trione G)

Milling (Trione Z)

DIO CNC Milling

3Shape Design

DIO Implant offers a full line up of implant designs and options to perfect your implant procedure under any situation with predictable and optimal results.UF, SM, Protem, Extrawide, FSN/FTNDIO holds best in class design, superior surfaces, state-of-the-art manufacturing, highest quality tools, drills and kits along with easy to learn protocols.

X Implant practice Volume 7 Number 1

CORPORATE PROFILE

DIO ImplantRenowned dental implants in over 70 countries

BEST IN CLASS MANUFACTURING

DIO Implant holds ISO 13485 certification

ISO 13485 is an International Organization for Standardiza-tion (ISO) standard that represents the requirements for a comprehensive quality management system for the design

and manufacture of medical devices.

UNIVERSAL FIXTUREUF

SUBMERGED SM

UNIVERSAL FIXTURE


CO

RP

OR

AT

E P

RO

FILEC

OR

PO

RA

TE

PR

OFILE



This information was provided by DIO.

• DIO Digital Solutions “Trione” brand lineup is composed of the “tried and true” best products and technologies globally.• Includes the most advanced intra-oral scanners, CAD applications & software and precision milling technologies.• DIO has developed highly advanced implant-oriented integrated digital applications and solutions designed for leading dental clinics and laboratories.• DIO is leading the “Paradigm Shift” from Analog to Digital Dentistry


Trios Scan

Milling (Trione G)

Milling (Trione Z)

DIO CNC Milling

3Shape Design

IP

Replacing two adjacent maxillary central incisors is one of the most challenging

esthetic clinical situations we face in providing dental implant therapeutics. The maxillary anterior region provides numerous esthetic, technical, and sequencing challenges. This article describes a surgical and restorative workflow for this clinical problem from treatment planning considerations to selection of a dental implant system that provides surgical and restorative advantages in order to enhance the esthetic outcome.

Case 1A 53-year-old female presented for functional surgical crown-lengthening procedure around her maxillary central incisors (teeth Nos. 8 and 9) prior to replacement of new crowns. The patient reported mobility of the existing crowns and an unpleasant odor in her mouth. According to patient history, these crowns were recent replacements of prior long-standing unesthetic crowns. The patient had an unremarkable medical history and had previously sought dental and dental hygiene care on a regular basis. Both teeth Nos. 8-9 had prior endodontic therapy (Figure 1). At her initial examination, a complete dental and periodontal evaluation, including full-mouth radiographs, was completed with photographic documentation. Significant marginal inflammation was noted around teeth Nos. 8-9 associated with poor fit of the crown margins and with recurrent decay. The patient demonstrated normal to thick biotype with rolled, reddened margins around the central incisors associated with

a high smile line and a dental history of mouth breathing (Figure 2). All other regions of her mouth demon-strated marginal gingivitis associated with retained interproximal plaque. The existing shape of her central incisor crowns were square and short and disproportionate in shape and size to her other natural anterior teeth. The existing crowns were carefully removed, and the underlying tooth structure was inspected. It was noted that there was inadequate core portion of the crowns, with only the coronal aspect of an endodontic post and composite retaining the crowns. There had been no ferrule portion of the tooth preparations in the cervical region (Figure 3). The likely contributing factor to the mobility of the crowns was the excessive tooth preparation resulting in crown flexure and marginal leakage resulting in recurrent caries. At her request, she was referred to a prosthodontist for further restorative treatment. A composite-based diagnostic wax-up was completed to assist in

determining optimum tooth height and shape. Treatment plan options were developed after discussing surgical and restorative considerations with the patient. These included functional surgical crown lengthening and new crowns, orthodontic extrusion of the two central incisors, followed by functional crown lengthening and new crowns, or extraction of the teeth and replacement with two dental implants and crowns. Based on the missing core portion of her teeth and the extent of decay around the post spaces, it was determined that extraction of the teeth and replacement with dental implants was the treatment of choice. Based on the anatomy of the tooth sockets and dimensions of palatal bone, identified by three-dimensional imaging CBCT, it was further determined that immediate extraction and placement of dental implants with intra-socket bone grafting was possible. The patient preferred interim fixed provisionalization during the initial healing phase, rather than any of the removable provisional options discussed with her. The surgical phase consisted of

Tackling a challenging esthetic clinical situation


CASE STUDY

Dr. Cary A. Shapoff illustrates a case replacing two adjacent maxillary central incisors

Figure 1

Cary A. Shapoff, DDS, has practiced in Fairfield, Connecticut for over 36 years. He is in private practice as a periodontist, and is a Diplomate and past director of the

American Board of Periodontology. He lectures both nationally and internationally on periodontal disease and its treatment, bone grafting procedures, and dental implant surgery. He has also written articles published in the Journal of Periodontology, Compendium, the International Journal of Periodontics and Restorative Dentistry, and The Dental Guide (Canada). He has been a consultant and lecturer for BioHorizons for 7 years.

Dr. Shapoff can be contacted at: [email protected].

Figure 2

Figure 3 Figure 4

CA

SE

ST

UD

Y


extraction of teeth with a flapless approach followed by careful curettage of the intact socket walls. Utilizing a surgical guide based on the diagnostic wax-up, two dental implants were placed, engaging the palatal wall of the intact sockets (Figure 4). The implants selected were the BioHorizons® Tapered Internal with Laser-Lok® microchannels on the coronal collar portion (3.8 mm x 15 mm with 3.5 mm prosthetic platforms). Precise three-dimensional positioning was established with the surgical guide. Following implant placement, the voids within the socket were bone grafted with a combination cortical and cancellous allograft (MinerOss®), and flared healing abutments were placed to support the soft tissues (Figure 5). The composite-based diagnostic wax-

Figure 5

Figure 6

• Onesystemwithsuperior3Dscanswithmultiplefieldsofview,2Dpanoramicimagingandoptionalone-shotcephalometricimaging

• Dedicated2Ddigitalpanoramicimagingwithvariablefocaltroughtechnologythatproduceshigh-qualityimagesin13seconds

• IntelligentDoseManagementprovideshigh-resolution3Dimagesandlowdoseascollimationlimitsexposuretoareaofinterest

• Fiveselectablefieldsofviewrangingfrom5cmx5cmto10cmx10cmhelpyougettheproperimagesizeforeachprocedure

To learn more about what a great image can do for your oral and maxillofacial surgery practice, visit carestreamdental.com/CS9300 or call 800.944.6365 today.

© Carestream Health, Inc. 2013 10232 OM DI AD 0114

TheCS9300Selectisreadytoworkhardforyourpractice. This technologically-advanced system will finally give you clarity, flexibility and, most importantly, complete control of your image quality and dosimetry. It will also show your patients how dedicated you are to their oral health.

It’s amazing what a great image can do for your practice.

Figure 7A Figure 7B


CASE STUDY

up was then bonded to adjacent laterals as a fixed provisional. Three months after surgical placement of the implants, screw-retained provisional crowns were fabricated onto PEEK abutments and were modified to achieve ideal tooth shape and gingival architectural framework (Figure 6). Maintenance of the interproximal bone between the implants was achieved with use of the BioHorizons implants with Laser-Lok microchannels. Minor modifications to the interproximal and facial dimensions of the composite crowns were made over a period of 12 weeks (Figures 7A and 7B). Once ideal tooth and gingival size and shape were established, custom, open-tray impressions were taken to capture the precise ideal subgingival form for final crown fabrication (Figures 8-9). Final crowns were then provisionally cemented and monitored for potential additional minor modifications (Figures 10A and 10B). The radiograph of the final crowns at 12 months demonstrates the maintenance of the crestal bone around each dental implant as well as maintenance of the interproximal bone between the implants (Figure 11).

DiscussionNumerous lessons can be learned from a critical review of this case.1. Evaluation of the failed crowns identified excessive tooth preparation and inadequate coronal portion of the tooth to provide predictable restoration with basic fixed partial dentures (crowns). In addition,

the design of the failed crowns did not mimic the tapered shape of her adjacent natural teeth. Critical documentation of tooth shape and size and smile analysis is an essential element of proper treatment planning. Lack of adequate ferrule and lack of coronal tooth portion should have precluded placement of the failed permanent crowns.

2. Dental implant treatment planning should include photographic documentation, diagnostic wax-up, evaluation of the gingival tissue biotype, position of the maxillary lip position relative to the gingival margin of the teeth, and shape and form of the intended implant restoration.

3. Surgical treatment planning should include three-dimensional imaging especially if a flapless approach is considered. Because of the thick gingival biotype and intact sockets of both teeth, immediate placement was considered. In other cases of high smile line, and thinner biotype, a delayed two-phased approach of grafting followed by implant placement would have been the treatment choice. A delayed two-phased approach would also be required if the remaining alveolar bone prevented adequate initial biomechanical stability at implant insertion.

4. Selection of the BioHorizons Tapered Internal implant was a key element of the success of maintaining interproximal bone between two implants. Use of the tapered 3.8 implant body allowed ideal positioning

in the palatal bone without encroachment on the facial bone dimension or elimination of the mesiodistal bone within the socket reducing initial stability. Intra-socket bone grafting with a calcified allograft minimized the horizontal dimension bone resorption often seen even with immediate implant placement. The use of the BioHorizons implants with the Laser-Lok microchannels was another key element in maintaining the ideal intra-implant bone level, which in turn supported the ideal height of the interproximal papilla. Numerous published articles have supported the concept of enhanced bone maintenance with the non-random Laser-Lok microchannels (Figures 12A and 12B). Additional animal and human clinical and histologic studies have demonstrated “functionally oriented” connective tissue attachment to the Laser-Lok surface along with inhibition of the epithelial downgrowth against the implant surface and Laser-Lok abutment surface (Figure 13).

Figure 12A Figure 12B

Figure 13: Polarized light micrograph

Figure 14

Figure 8 Figure 9 Figure 10A

Figure 10B Figure 11

Figure 15

CA

SE

ST

UD

Y


5. Maintaining support of the facial and interproximal tissue contours with use of the flared healing abutments assisted in recapturing the proper gingival contour around the provisional crowns. This could have been further improved by fabrication of “custom” healing abutments utilizing the BioHorizons 3inOne abutment and composite. This customized technique is used often in this practice but was not utilized in this case.

6. Fabrication and modification of the well-contoured, screw-retained provisionals by the prosthodontist, Dr. Jeffrey O’Connell, (Bridgeport, Connecticut) was also another key element in achieving ideal tooth shape and gingival framework. In addition, the established subgingival contours were captured in the final impression technique utilizing the BioHorizons open-tray copings modified with resin. The excellent working relationship of the prosthodontist and his dental laboratory technician also needs to be mentioned in achieving natural-looking, all-ceramic crowns. This case was completed before the company release of CAD-CAM custom abutments with Laser-Lok microchannels (Figure 14). Use of these abutments would have further enhanced the attachment of soft tissue to the abutment surface resulting in protection of the underlying crestal bone. In summary, the patient was successfully restored with two single-crown dental implant restorations following an interdisciplinary workflow from treatment planning through final restorations. The use of the BioHorizons Tapered Internal dental implant with Laser-Lok microchannels was an integral part of the success of this case. In similar cases where the gingival biotype is thinner, I would have considered using the platform switched BioHorizons Tapered Internal Plus implant in order to create a thicker dimension of marginal tissue around the abutments (Figure 15).

Count on us for INNOVATIVE design to keep your practice in the forefront.

INTEGRATED software for seamless workflow, office to operatory.

And INTERACTIVE products that promote better patient relationships.

© Carestream Health, Inc. 2013. RVG and WinOMS are trademarks of Carestream Health. 10232 OM DI AD 0114

Share our passion for your practice online.

Visit www.carestreamdental.com or call 800.944.6365.

Share our passion for your practice online.

CS 9300 SELECT

RVG 6100

YOUR PRACTICE. OUR PASSION.

CS WinOMS CLOUD

8765_Bundle ad-3.8x10.7.indd 1 12/20/13 11:13 AM

IP

BackgroundDental problems of cancer patients are often worsened when the patient undergoes chemotherapy. Dentists and other dental care professionals have seen this. Dental problems definitely worsened for Dr. Richard G. Dong, a retired engineer, during his 3½ years of treatment with the chemo-therapeutic drug Bacillus Calmette-Guerin (BCG), a live bacteria injection used to treat bladder cancer. The problems included persistent infections developing in two existing molar dental implants on teeth Nos. 19 and 30. Dr. Bryan R. Krey is the oral surgeon performing the dental implant procedures and has followed Dr. Dong’s problems and his inventive ways of handling them. This article describes the simple instruments and techniques Dr. Dong developed that saved one of the existing implants and, together with Dr. Krey’s help, extended the life of the other by an estimated 2 years. Conclusions reached by Dr. Dong and Dr. Krey are summarized at the end of the article regarding the handling and designing of implants for individuals on chemotherapy or who had chemotherapy, and who had experienced worsened

dental problems while on chemotherapy. Dr. Dong is a nonsmoker, with no diabetes or other systemic disorders. He exercises regularly and eats a healthy diet.

Effects of an altered immune systemThe chemotherapy was to train Dr. Dong’s immune system to fight the cancer. The following might or might not be medically established, but from an engineer’s point of view, this means the immune system will be altered; and therefore, various changes in immunity reactions will progressively show up as the alteration increases. This was confirmed by the fact that various forms of immunity reaction came forth one after the other over Dr. Dong’s 3½ years of treatment. This included arthritic auto-immunity reactions, weakened ability to fight off certain bacteria, such as those causing dental problems and those caus-ing cellulitis. Dr. Dong’s last treatment resulted in a severe rash all over his body, as his immune system became sensitized to the drug. Thank goodness it was the last treatment; who knows what else might have arisen next. General tiredness, headache-nausea reactions to weather changes, and allergic reactions to certain foods also developed. The bladder became hyper from three rounds of surgeries and from the prolonged exposure to the chemotherapy drug. Hyper is defined here as constant urgency and frequency to urinate on an hourly basis. Therefore, this is also at least partly an immunity reaction. Besides the immune system becoming

more able to fight the cancer, a secondary positive change was that his seasonal hay fever became much milder. Not everyone would react the same way to this particular chemotherapy, and therefore, not everyone is necessarily going to have the reactions mentioned. Everyone’s immune system is different. This is becoming increasingly clear in general cancer research. Immune systems in individuals could vary widely as revealed in current research using humanized mice. The immune systems of numerous individuals are grown in mice to study their reactions to various cancer-fighting drugs and various cocktails of the drugs. The reactions were found to vary widely among the immune systems. Ideally, the longer the chemotherapy Dr. Dong received could continue, the more his immune system would be altered to fight the cancer. However, it became apparent to him that the likely reason the standard duration is set at 3½ years is because that is probably what a typical patient could tolerate before the immunity reactions become more intolerable than the cancer. However, at the current level of alteration, Dr. Dong prefers to put up with current reactions than to have his immune system return to how it was, thus allowing the cancer an increased chance of recurring.

Implant failure increases when the implant procedure is timed near or during chemotherapy Bone formation takes place slowly to fill in

A chemotherapy patient’s experience with dental implants


PATIENT INSIGHT

Dr. Bryan R. Krey and retired engineer Dr. Richard G. Dong join forces to facilitate implant placement during cancer treatment

Figure 1: Radiograph prior to placement of tooth No. 19 implant

Richard G. Dong, PhD, was born and raised in Sacramento, California. He earned his BS and MS degrees in Mechanical Engineering at the University of California in Berkeley, California. He worked for 2 years at the Aerojet-General Corporation in Sacramento, California. He returned to the Berkeley campus and earned his PhD in Structural Mechanics. He then worked at the Lawrence Livermore National Laboratory in Livermore, California, as a research engineer and as one of the technical reviewers for the laboratory’s Nuclear Test Program. He retired in 1993. He lives in Danville, California, where he and his wife raised two children.

Bryan R. Krey, DMD, was born and raised in Brentwood, California. He earned his dental degree at Oregon Health and Science University in Portland, Oregon, in 1993. He completed his Oral Surgery residency at Highland Hospital in Oakland, California, and later completed his board exams and is a Diplomate of the American Board of Oral and Maxillofacial Surgery. He is in private practice with offices in Berkeley and Orinda, California. He lives in Lafayette, California, with his wife and four children.

Figure 2: Radiograph with tooth No. 19 and tooth No. 30 implants in place. Prior to restoration. Ideal bone levels


PATIENT INSIGHT

the hole left from a tooth extraction. After 4 months, enough bone has usually formed to enable the implant post to be installed. But an X-ray would clearly indicate the bone has not yet reached normal density. Four months after that, the crown is usually installed. An X-ray would indicate the bone density is better but still not at normal level. From an engineer’s perspective, the bacteria could now begin accumulating at the crown-implant junction. The surface transitioning from the crown to the post would not be perfectly smooth, as could be seen on the implant removed from Dr. Dong’s molar tooth No. 30 site. The crown and post are minutely different in diameter and roundness such that a tiny ridge and a tiny shelf are formed there. Tiny gaps likely also exist at various locations where the crown mates with post. Such imperfections are deeply located and somewhat hidden since they are not easily reached during brushing and flossing. Bacteria could accumulate at these imperfections and then migrate to where the post meets the bone to initiate bone loss. Also, as pointed out by Dr. Dong’s regular dentist, the migration is intensified by the “pumping” action during food chewing. There must be reasons why bone loss occurs after the crown is installed, and the factors mentioned seemed logically to be why. If bone density were less than normal,

the initiation of bone loss would be easier, and continued bone loss would be faster. In addition, if the patient’s immune system’s ability to fight the bacteria were weakened by chemotherapy, the entire bone loss process would progress even faster. Under this condition, the pocket formed by bone loss could quickly grow to where the bacteria would have many corners and crevices in which to hide and colonize. Once colonization occurs, the bacteria would be more difficult to dislodge and eliminate, bone loss might be slowed with extraordinary care but not stopped, and the implant would eventually fail. Under normal circumstances, with the patient’s immune system well able to fight off the bacteria, bone loss could initiate but would stabilize and essentially stop. The implant would then be successful. An X-ray could show a small amount of bone loss, but that would be considered normal. Dr. Dong’s experience with implants appears to match the descriptions in the preceding paragraphs. Four of his molars at different times needed to be replaced with implants, and chemotherapy affected all four. The following are the timelines relative to the beginning or ending of chemotherapy.

Molar 19 • Implant post was installed 1.25 years

before chemotherapy began. • Crown was installed 0.88 years before

chemotherapy began.•While chemotherapy affected this

implant, the implant was saved by the procedure developed by Dr. Dong.

Molar 30• Implant post was installed 1.0 year

before chemotherapy began. Crown was installed 0.63 years before

chemotherapy began.• The implant failed due to effects of

chemotherapy, in spite of Dr. Dong and Dr. Krey’s best efforts, and was removed 1.4 years after chemotherapy ended. Thus, the implant lasted 5.53 years after the crown was installed.

• The implant procedure is currently being repeated. Implant post is not yet installed.

Molar 18•Molar 18 was extracted 1.06 years

after chemotherapy ended and about 0.06 years after the chemotherapy drug completely left the body.

• Implant post was installed 1.4 years after chemotherapy ended and about 0.4 years after the chemotherapy drug completely left the body. Crown is not yet installed.

Molar 31•Molar 31 was extracted 1.7 years after

chemotherapy ended and about 0.7 years after the chemotherapy drug completely left the body.

• Implant post is not yet installed.• The fact that molar 31 went bad quickly

could indicate that Dr. Dong’s immune system remains altered and was thus unable to fight the bacteria adequately. His urologist treating the cancer and his primary care doctor indicated his immune system is likely to remain altered for the rest of this life, especially since chemotherapy was done at his somewhat advanced age of 70 years.

Dr. Dong had quite a few dental problems even before he had cancer. According to his dentist, he keeps his teeth so clean; he should not have so many problems. Consequently, it must be in his genes. The need to replace molars

Figure 5: Radiograph showing loss of tooth No. 30 im-plant, restored tooth No. 19 implant, and recently placed tooth No. 18 implant. Tooth No. 18 implant features internal abutment connection and platform switching

Figure 3A: Restored tooth No. 30 implant with vertical bone loss

Figure 3B: Prior to tooth No. 19 implant being restored.

Figure 4: Restored tooth No. 30 implant. 2011. Severe bone loss.

MEISINGER USA, L.L.C.10200 E. Easter Ave. • Centennial • Colorado 80112 • USA Phone: +1 (303) 268-5400 • Fax: +1 (303) 268-5407 • Toll free: + (866)[email protected] • http://meisingerusa.com

Sinuslift

ALL YOU NEED!Crestal-Lift-Control

BCL00

This system for the internal sinus lift facilitates a simple, safe augmentation of the sinus floor. Elevation occurs during the transcrestal drilling process. The stop sleeve system is coordinated with special instruments to prevent the membrane from being injured or punctured. In addition to the especially atraumatic design of the Crestal drill with its four cutting edges and the concave head for safely forming a conical bone flap, this Crestal drill is also ideal for collecting bone chips.


PATIENT INSIGHT

19 and 30 with implants happened before chemotherapy began. However, infections and gum swelling, bleeding, pocket formation, and bone loss started happening soon after chemotherapy began. The molar 19 implant remains successful while the molar 30 implant failed. Molars 19 and 30 are at the same locations at opposite sides of the lower jaw. Therefore, their environments should be essentially identical. A notable difference is the molar 19 implant had 3 months more to increase bone density than the molar 30 implant had before chemotherapy began. The 3 additional months apparently enabled the bone density for the molar 19 implant to reach a high enough level to prevent the rate of bone loss from becoming unstable. Molar 18 experienced multiple problems while Dr. Dong was undergoing chemotherapy. The dentist and Dr. Dong did their best to save molar 18, but couldn’t. It seemed that once the bacteria gained a foothold, it is very difficult to stop the destruction when the immune system is unable to fight the bacteria well enough. An infection occurred at the periapical region of molar 31’s roots, and it led to the molar’s loss. Age-related gum recession exposed the bifurcation point between the roots and allowed bacteria to enter. An earlier root canal eventually resulted in root brittleness, and one root developed a crack that allowed the bacteria to migrate to the lower region of the roots. The entire process happened very quickly and could not be caught even with biannual hygienic cleaning and inspection by the dentist. The process apparently accelerated because the immune system was unable to fight off the bacteria well.

Stopping the 4-week cycling between infections and healingThe gum surrounding molars 19 and 30 implants started getting infected, swollen, and bleeding shortly after chemotherapy began, and worsened as chemotherapy continued. Pockets started to form, and a bit of exudate could be expelled when pressure is applied to the pockets. The problem occurred at the buccal face side of the implants but not at the lingual side. For some reason, this is common. Perhaps the pressure and motions of the tongue kept the bacteria from gaining a foothold at that side of the implants. Dr. Dong tried handling the problem by brushing, flossing, and using an

interdental brush, but none worked. It became apparent that blood clots and other materials the bacteria could cling to or hide in must be removed, and that some method of flushing them out needed to be developed. Therefore, he made some instruments consisting of various shapes of plastic toothpicks, toothpick holders that hold toothpicks at 90º from the handle, an eyedropper, a length of flexible plastic tube 0.05 inches outer diameter, and a covered low container of Listerine®. Plastic toothpicks rather than wooden ones were used because plastic ones would not fray and lose their shape. The steps in the procedure Dr. Dong developed are as follows:

Step 1:• He used the smooth, round blunt end

of a toothpick holder to gently rub against the pockets to expel the exudate accumulated in the pockets.

• The exudate would be a larger amount and a bigger concern when infection exists. If infection does not exist, the exudate would be a smaller amount and of minor concern.

Step 2:• A blunt toothpick was used to scoop up

the exudate.• The mouth was rinsed with plain water

before performing the next step.

Step 3:• The reason for omitting this step here will

be explained later in the article.

Step 4: • A more sharply pointed toothpick

is used to slightly enlarge the front and rear openings of the pocket and to mechanically gently dislodge the bacteria from the surfaces of the pocket. The center edge of the pocket is usually still attached to the post, and this part of the pocket is not to be forced open. Otherwise injury would occur leading to infection. Step 4 is performed only if the openings of the pocket are large enough to allow the toothpick to easily enter, as was the case for the molar 30 implant.

• If the openings of the pocket are very small, as is the case for the molar 19 implant, Step 4 is omitted, and Step 5 would still be effective.

• The mouth is rinsed before going to Step 5.

Step 5:• The syringe made with an eyedropper

with a length of 0.05-inch outer diameter flexible plastic tube fastened to it with a glue gun. This is used to squirt Listerine into the pocket to flush out the bacteria and any other materials. The tube is inserted into one of the two openings widened in Step 4, and that part of the pocket is flushed. This procedure is repeated with the other openings. Flushing is repeatedly alternated between the two openings until all the Listerine in the eyedropper is used up.

• If the pocket was bleeding to begin with, Step 5 was performed three times to stop the bleeding. A blood clot must not be allowed to form in the pocket. Listerine apparently has an ingredient that helps stop the bleeding.

• As explained, Step 4 is omitted for the molar 19 implant. Squirting the Listerine into the pocket through openings as they already exist without being further opened by Step 4 seems to work adequately for the molar 19 implant.

• The mouth was rinsed, and the usual teeth brushing was then performed for the entire mouth.

• A flexibility syringe made as explained works better and safer than using a standard rigid syringe. The plastic tube was held at the opening of the pocket with one hand, while the other hand squeezed the eyedropper. The flexibility of the plastic tube enabled the tube to be easily and safely held at the opening of the pocket. This is likely to be much more difficult to do using a standard rigid syringe.

Step 3 is left blank in the above list for the following reason. The four steps listed would dislodge and flush out the bacteria and thus promote healing. However, as healing progresses, the gum would tighten against the post. Steps 4 and 5 would then become more difficult and less effective to perform. Consequently, the bacteria begins to re-establish in the pocket. This caused infection to start again. The infection and swelling would cause the openings of the pocket to enlarge. This then enables Steps 4 and 5 to be more easily and effectively performed. Healing would then be promoted again. The net result is we get 2 weeks of healing followed by 2 weeks of infection, swelling, and bleeding. This 4-week cycle continues to repeat with only the four steps listed above.


PATIENT INSIGHT

Dr. Dong discovered that by adding a Step 3, the 4-week cycle would be stopped. In Step 3, he uses a toothpick, not quite as pointed as the one used in Step 4, to clean the gum line around the post where brushing and flossing would not reach. This would be where a tiny trough is formed over the length of the edge of the pocket that remains attached to the post. This is the length of the edge of the pocket that is not to be opened in Step 4. Apparently, this trough provides a lodging site for the bacteria. When the pocket could not be flushed out very well, these bacteria would migrate into the pocket and add to those not flushed out. The total would reach a level that would cause infection to start. Step 3 is as follows:

Step 3:• Use a toothpick not quite as pointed

as the one used in Step 4, and clean along the gum line at the face side and the tongue side of the implant. While cleaning the tongue side is probably not necessary, you might as well do it just in case.

• The mouth is rinsed before performing Step 4.

By adding Step 3, the 4-week cycle was stopped. Bone loss in the molar 19 implant was stabilized, and the implant was saved. Unfortunately, the addition of Step 3 was unsuccessful in saving the molar 30 implant. The pocket there had become so large and deep with so many corners and crevices in which bacteria could hide that while the 4-week cycle was stopped, enough bacteria remained in hiding to cause continued bone loss even without apparent infection. Dr. Krey tried cleaning out the pocket to minimize the places where bacteria could hide, but as he later explained, once the bacteria colonized within the pocket, they were very difficult to completely dislodge and flush out. In this case, “colonization” means the bacteria became established in some hard-to-clean and flush locations in which to hide and breed. Nevertheless, by stopping the 4-week cycle and thus slowing the rate of bone loss, the molar 30 implant’s life span was extended by 2 years, by Dr. Dong’s estimate.

Best to repeat the procedure every 12 hours Based on Dr. Dong’s experience, the procedure described is best repeated

every 12 hours. This enables the openings of the pocket, in the case of the molar 30 implant, to remain reasonably open so that Steps 4 and 5 could be performed effectively. If more than 12 hours have passed, the openings would decrease to where Steps 4 and 5 could be more difficult or impossible to perform. Then infection could start again. If the procedure were performed more frequently than every 12 hours, injury and inflammation could occur leading to infection. Every step of the procedure must be done not too gently or too forcefully, even while squirting Listerine into the pocket. Enough force is needed to dislodge or flush out the bacteria, but too much force can cause injury followed by infection. The tissue inside the pockets is very tender and fragile since it is well protected and not toughened by exposure during brushing, flossing, and contact with foods.

ConclusionsBased on the differences in the behaviors of the molars 19 and 30 implants, and how installing the crown on the post could initiate bone loss, Drs. Dong and Krey came up with two conclusions. If the patient is under chemotherapy or had chemotherapy in the past, and if dental problems significantly worsened while on chemotherapy, then Conclusion 1 would apply.

Conclusion 1Installing the crown onto the post should be delayed to allow more time for the bone density to reach a high enough level to prevent easy initiation of bone loss followed by a fast rate of bone loss. How much delay time is required to achieve this is not known at this time. However Dr. Dong’s experience indicates waiting 1.25 years after the post is installed would most likely achieve the desired result. But waiting 1.25 years is probably longer than really necessary. According to Dr. Dong’s experience, an increase of 0.25 years in doing the implant procedure before chemotherapy commenced was enough to make a significant difference. While this is not the same as waiting 0.25 years before installing the crown onto the post, it does confirm that allowing extra time for the bone density to increase before chemotherapy begins is beneficial. Therefore, instead of waiting 1.25 years to install the crown, we could try doubling or tripling the standard waiting time of 4 months after the post is installed before installing the crown and

see if that is enough to achieve the desired result. Dr. Dong plans to try this for the molars 18, 30, and 31 implants and could report on the results at a later time. The post installed at the molar 18 site has a new design to help hinder the migration of bacteria to where the post meets the bone. The new design has the same overall proportions as the preceding design except a location that is a short distance below the top has a smaller diameter. This forms a circumferential grove for the gum tissue to grow into. This makes the path more difficult for the bacteria to negotiate to reach where the post meets the bone. In Conclusion 2, Drs. Dong and Krey present another possible new design for the implant post following a different approach to preventing bacteria from migrating to where the post meets the bone.

Conclusion 2As stated earlier, tiny imperfections, such as a ridge, a shelf, and gaps, formed where the crown meets the post are possible sites for the bacteria to accumulate. These sites are not easy to reach during brushing and flossing. The bacteria could accumulate there and then migrate to where the post meets the bone to initiate bone loss. This chain of events could be avoided if the post and crown were reconfigured. The crown-post assembly has the shape of a wine glass with a very stout stem minus the base. The tiny imperfections would be located where the cup meets the stem. If the imperfections were relocated higher up onto the cup, then any bacteria accumulated there would be more exposed and more easily removed by brushing and flossing. This would eliminate the imperfections as sites where bacteria could accumulate, and from which to migrate to where the post meets the bone. The post would have a head similar to how a flat-head wooden screw has a head. The crown would be flatter to accommodate the head on the post. The appearance might not be desirable if the base of the implant is visible to others. The implant post design presented would benefit any dental implant recipient regardless of whether or not the recipient is going through chemotherapy or had worsened dental problems while on chemotherapy in the past. IP

CO

NT

INU

ING

ED

UC

AT

ION


Traumatic injuries to the anterior teeth can be a tragic experience for the

patient and require thorough treatment planning, experience, and skill on behalf of the dentist. Advances in techniques used both in endodontics and implantology have allowed us to save more of the patient’s own teeth — and patients’ wishes to retain their own teeth, if possible, must be respected. In this case study, the use of membrane and autogenous-free bone regeneration with simultaneous implant placement (Fairbairn, 2011; Podaropolous, et al., 2009), as well as microscope-enhanced endodontics, helped achieve the result the patient desired.

IntroductionDental trauma often involves a team of dental practitioners: the general dentist along with one or more specialist dentists. Since trauma is not a common occurrence in general practice, management of traumatized teeth can be both demanding

and challenging, as it is accompanied by emotional factors on the patient’s part. Horizontal root fractures can be classified according to the location of the fracture line (apical third, middle third, and cervical third). Injury factors to the tooth, such as location of the fracture line, mobility of the coronal fragment, the degree of dislocation of the coronal fragment and diastasis between fragments (rupture of the pulp at the fracture site), stage of root development (immature or mature root), and age of the patient (growth of the alveolar process) have the greatest influence upon healing (Andreasen, et al., 2004; 2007). In the horizontally fractured tooth, necrosis of the pulp usually occurs in the coronal fragment, while the pulp of the apical fragment remains vital (Andreasen and Hjorting-Hansen 1967; Hitchcock, et al., 1985). This provides a basis for treatment of the horizontally root fractured teeth. In permanent teeth with horizontal fractures in the apical and middle thirds, root treatment of the coronal fragment only with gutta percha (with calcium hydroxide dressing in the interim) has been proved to be successful, whereas unfavorable outcomes have occurred when both fragments have been endodontically treated with gutta percha (Cvek, et al., 2004; 2008). The aim of this is to form a calcific

barrier at the apical end of the coronal root fragment, in the same way as treating a non-vital immature tooth (by apexification). Mineral trioxide aggregate (MTA), was developed in the 1990s as a root end filling material (Torabinejad, et al., 1993; 1995). Since then, it has been used extensively in all aspects of endodontic treatment. It is associated with favorable apical healing when used as an apexification material in immature teeth with open apices (Pace, et al., 2007; Simon, et al., 2007; Felippe, et al., 2006) because it encourages hard tissue formation (Pitt Ford, et al., 1996; Nair, et al., 2008; Accorinte Mde, et al., 2008), is biocompatible (Pitt Ford, et al., 1996; Nair, et al., 2008; Aeinechi, et al., 2002), provides a good seal (prevents microleakage) (Torabinejad, et al., 1993; Pitt Ford, et al., 1996; Lee, et al., 1993; Lawley, et al., 2004), and is nonresorbable (Torabinejad and Chivian, 1999). Consequently, MTA is the treatment of choice instead of gutta percha for root filling the coronal segment of teeth with horizontal root fractures. This case involves three teeth that were involved in trauma and the multi-disciplinary approach used to treat them. After careful assessment, sometimes the only option is removal and replacement with a dental implant. Guided bone regeneration is generally needed in trauma cases where dental implants are to be placed due to bone damage during the trauma or as a result of post-traumatic infection. The co-

Multi-disciplinary approach to the treatment of traumatic root fracture: a case study

Drs. Peter Fairbairn and Sharon Stern present a multi-disciplinary approach to tackling a tricky trauma case

Dr. Peter J.M. Fairbairn, BDS, is principal of the referral-based Scarsdale Dental Aesthetic and Implant Clinic in Kensington, London. He is visiting Professor in the Department of Periodontology and Implant Dentistry at the University of Detroit Mercy School of Dentistry in Michigan (United States). Dr. Fairbairn can be contacted at [email protected].

Dr. Sharon Stern graduated in 1999 as a general dentist from the University of the Witwatersrand (South Africa), before moving to London where she worked in private practice and the Acute Dental Care Department at Guys Hospital. In 2006 she completed the Certificate in Restorative Dentistry at Eastman Dental Institute. Dr. Stern completed her specialist training in endodontics at Guys Hospital in 2010 and was accepted on the GDC Specialist Register for Endodontics in 2010. Since qualifying as an endodontist, Dr. Stern works mainly in private practice and is involved on a part-time basis in the postgraduate clinical program in endodontology at Kings College London. She has also been the main author of a research article and co-author in a peer-reviewed journal article. Dr. Stern can be reached by email at [email protected] or on 020 7937 2160.

Educational aims and objectivesThe aim of this article is to present a multi-disciplinary case study thatdemonstrates how patients’ needs can sometimes be better met when clinicians work together.

Expected outcomesCorrectly answering the questions on page 31, worth 2 hours of CE, will demonstrate the reader can: • Recognize the recommended approach for dealing with root

fracture.• See where implant therapy and endodontics can combine.• Identify some of the principles behind soft tissue grafting and

healing.


CONTINUING EDUCATION

author has used only alloplast or synthetic particulate graft materials for the last 10 years using no autogenous (blocks, chips, or scrappings) for the last 9 of them. A delayed immediate placement protocol is the standard procedure where the tooth or root is removed carefully, so as to not damage the residual bone, and then left to heal for 3 weeks. This standard protocol — employed in more than 1,800 cases in the 10 years by the co-author — allows for soft tissue closure yet ensures the preservation of adjacent bone prior to the phase of modeling (Schropp, et al., 2003). Ridge preservation, rather rebuilding the profile of the modeled ridge, can be both more time efficient and less traumatic for the patient. Bone healing is further improved by not using a traditional (collagen-type) membrane that inhibits periosteal blood to the graft site, which accounts for 85% (or more) of the blood supply to the site. The stability and soft tissue cell occlusive properties needed for successful bone regeneration (Schenk 1995) are achieved by a CaSO4 (calcium sulfate) element in the graft material; hence, the graft is its own membrane.

Case The 25-year-old male patient was involved in a motor vehicle accident that resulted in trauma to his UR1, UR2, and UR3. Horizontal root fractures were evident in the mid to apical third of the UR2 and UR3 (Figure 1). All four teeth were splinted at his local hospital’s dental unit after the initial visit to the accident and emergency (A&E) and later treated by his general dental practitioner. The case was referred to the authors 3 months post-trauma with a swelling and pain associated with the UR2. Clinical examination revealed that the UR2 was

grade 3 mobile; the UR1 and UR3 were firm. The UR3 had not responded to sensitivity tests (electric pulp testing and cold testing). Periapical radiographs of the associated teeth (Figure 2) showed that both the UR2 and UR3 had horizontal root fractures at the junction of the middle and apical third of the roots. The UR2 was root filled; the coronal fragment was laterally dislocated; the diastasis between the coronal and apical root fragments was over 2 mm; and a lateral radiolucent area was evident. The UR3 was not root filled, the diastasis was less than 1 mm, and lateral radiolucent area was evident. The UR1 was root treated but not ideally obturated; however, no apical radiolucencies were associated with these roots. The patient was determined to retain both the UR2 and UR3. Since the 13 was not mobile, the diastasis between the coronal and apical fragments was less than 1 mm and had no associated pockets, the prognosis for treating this tooth was good. However, the fact that the UR2 had grade 3 mobility, the only option for the lateral incisor was an extraction. This prospect suited the patient who had been initially referred for the placement of two implants, and the necessary treatment consent was completed. The initial treatment would be to secure the future of the canine, and endodontic treatment was arranged.

Endodontic treatment of the UR3A decision was made to treat only the coronal fragment of the UR3 as the apical fragment was assumed to be vital (Andreasen and Hjorting-Hansen 1967; Hitchcock, et al., 1985). Rubber dam was secured over the tooth using a Q9 rubber dam clamp (Dentsply Ash instruments, UK). The access was established with a long tapered diamond bur. The pulp chamber

was then fully accessed and refined using a BUC-1 ultrasonic tip under the copious water spray. One canal was identified with the aid of an operating microscope (Global G3, Global Surgical Corporation) using a DG16 explorer probe (Dentsply Ash instruments). The working length of the root canal of the coronal fragment was determined using an apex locator (Raypex® 5; VDW). A working length radiograph was taken to verify the apex locator readings . The canals were instrumented to working length with hand K-Flexofiles® (Dentsply Maillefer) to an ISO size 70 using the balanced force technique. The UR3 was root filled to the level of the root fracture with a minimum of 4 mm of mineral trioxide aggregate (MTA) (Angelus) using the Messing Root Canal Gun (Miltex) to deliver the MTA (Figure 3). An activated, stainless steel ultrasonic tip was used to apply ultrasonic energy to a number 2/3 Machtou condenser (Dentsply Maillefer), which was used to pack, flow, and settle the MTA. The rest of the root canal was backfilled with gutta percha, and the access cavity was restored with composite (Filtek™ Supreme XT Universal Composite, 3M ESPE). A postoperative radiograph of the completed root canal treatment was taken (Figure 4). There is slight extrusion of the MTA beyond the fracture line; however, since MTA is biocompatible, the prognosis of the treatment is still good.

Implant placement at UR2The surgical phase was then initiated with the removal of the fractured lateral incisor. A plastic partial denture was made as a temporary rather than the preferred resin-bonded bridge due to cost factors and the patient’s desire not to involve adjacent teeth. The root tip was removed using a

Figure 2BFigure 1: Trauma area 13, 12, and 11 Figure 2A Figure 3: MTA placed Figures 2A and 2B: Radiograph at 3 months post-trauma

CO

NT

INU

ING

ED

UC

AT

ION


Periotome (Figures 5A and 5B), taking care not to damage the buccal plate any further. Probing the socket showed the resultant buccal bone defect (Figure 6) and the thin biotype of the gingiva. The partial denture was then fitted (Figure 7), and the site was then allowed to heal for 3 weeks. After the period of soft tissue healing, we generally have good enough soft tissue closure (Figures 8 and 9), but the effects of hard tissue modeling can already be seen due to the extent of the infected site bone loss. A site-specific flap is then raised not to affect the papillae of the adjacent teeth. The concept of employing the membrane in the graft (Fairbairn 2011; Podaropolous, et al., 2009) allows this flap

to be smaller, reducing patient trauma, as well as allowing the all-important blood supply from the periosteum unimpeded access to the site. The periosteum in a bone damage site also plays a role in the induction of stromal cell derived factors (Fairbairn 2011), which results in an increased presence of mesenchymal cells important for healing (Zhao, et al., 2012). Thus, the author feels the use of traditional collagen-type membranes may be a hindrance rather than a help to the body’s healing (Gutta, et al., 2009). The site was then vigorously curetted to ensure the removal of any granulation tissue. The bacteriostatic nature of CaSO4 enabled the co-author to dispense with

the need for the use of chlorhexidine, even though its effect on fibroblasts is debatable. A DIO 3.8 mm by 12 mm implant (DIO Implant Corporation) was placed slightly palatally in the socket (Figures 10-11) to the desired torque of 35 Nm. The author always places the implant at the time of grafting — even in extreme bone loss cases — due to the inherent regenerative capabilities of the titanium implant (Brunette 2001), as well as its mechanical stabilization of the particulate graft. The implant can thus be considered the most important of graft materials — as well as aiding the bone regeneration, it will be needed to attach the abutment and crown in the near future.

Figure 5BFigure 4: Completed root canalFigures 5A and 5B: Use of periotome to remove the root tip

Figure 5A

Figure 8: Three weeks later showing soft tissue healingFigure 6: Defect shown by probe Figure 7: Partial denture fitted

Figure 10BFigure 9: But also showing hard tissue lossFigures 10A and 10B: Implant (DIO 3.8 mm x 12 mm) placed palatally, with site-specific flap retaining papillaeFigure 10A



The Osstell reading (Bornstein, et al., ND) was then taken using a type 49 peg, which here was 38 ISQ, a low reading. Always make sure to correctly seat the peg as shown (Figure 12) to prevent incorrect readings. The particulate graft (Vital, Biocomposites) was prepared according to the manufacturer’s instructions and packed into the site and allowed to “set” using gauze to restrict the blood ingression into the site for a 3-minute period (Figure 13). This ability to set and hence become more stable has been shown to lead to more successful graft site with improved bone regeneration (Schenk 1995). The site was then closed carefully and sutured using 5.0 Vicryl™ sutures (Ethicon, Inc. [Figure 14]). The CaSO4 element of the material will supply a soft tissue cell occlusive barrier for the first 3 weeks (patient dependent) while being vascularly porous to ensure angiogenesis. This vascular porosity increases as the CaSO4 element

Figure 15: Flap raised at 3 months to show new bone and some remnant graft material (less than 15%)

Figure 14: Sutured carefully with 5.0 Vicryl

Figure 18: Fitting healing cap and denture

Figure 16: Round bur used to remove excess bone

Figure 17: Core sample showing small graft remnants at 3 months, H and E stain (Dr. Mangham)

Figure 19: Soft tissue healed after 1 week

Figures 13A and 13B: The Set Vital graft, control bleedingFigure 12: Osstell smart peg (type 47) fitted to DIO implant

Figure 13BFigure 13AFigure 11: Adjacent bone prior to modeling, need to graft

bio-absorbs, providing elements for the bone regeneration process in the structure of the BTcP (99% pure beta tri-calcium phosphate) element of the material (Smeets, et al., 2009). It is also noted that most particulate graft materials (Vital in particular) exhibit a negative iso-electric charge in an aqueous solution, which attracts host bone morphogenetic proteins (BMPs) such as osteoponin and osteocalcin in greater numbers to the site (Hunt and Cooper 2012). These then attract the host’s negatively charged mesenchymal cells (osteoblasts) and therefore up-regulating the host healing response. Hence, the author has not used any autogenous bone in the last 9 years as he feels introducing dead bone to the site delays the healing process due to the initial osteoclastic phase. Not using autogenous bone results in reduced patient morbidity and hence a greater acceptance of the surgical

procedures. After 12 weeks, a flap was then raised to show new bone formation, with some remnant graft material on the surface (Figure 15). A round bur (Meisinger) was used to access the implant head completely (Figure 16), which is important to seat the Osstell peg perfectly and prevent false readings. The full bio-absorption of the graft material is important in returning the site to true human host bone. Numerous research papers by the co-author (Leventis, et al., 2012) and others have shown that by 10 weeks up to 85% of the graft material may have already bio-absorbed to facilitate improved bone regeneration in line with the host healing process (Figure 17). The flap was also used to move the attached, keratinized gingival tissue buccally (a small rollover type flap) when the healing cap (SANH 4224) was fitted and the denture re-fitted for another week (Figure 18). The further improvement in the profile

CO

NT

INU

ING

ED

UC

AT

ION


can be seen in Figure 19. The correct abutment (SACN 4835T) was selected to move the crown margin to a level 1 mm below the gingival margin despite the deeper placement of the implant (Figure 20). This was used to optimize the platform switching benefits of this indexed tapered abutment system and improve the soft tissue seal above the implant. An IPS e.max® crown (Ivoclar Vivadent) was made and cemented with Premier® Implant Cement (Premier Products Co.) The excess was removed during the “gel” phase to ensure no residual cement was left sub-gingivally. The patient was happy with the outcome and was asked attend every 6 months to enable long-term assessment of this more complicated case.

Review At the first review appointment, an improved buccal profile and gingival health was observed (Figure 21) with stippling and no bleeding on probing despite the excess cement of a recently re-cemented veneer on the UR1. Radiographically, the bone density appeared to have improved in the cervical area (Figure 22), possibly as a result of functional remodeling and the final “turning over” of the remnant graft material, which can take up to 9 months depending on patient physiology. This full bio-absorption of the graft material is important to return the host bone back to a healthy state without the presence of foreign hydroxyapatite (HA), which may impede the natural osteoclastic and osteoblastic cycle of natural bone. Once loaded, there appears to be little change in the profile in line with Wolff’s Law, in that function is essential to retain bone. Twelve months after the UR3 was root treated, the lateral radiolucent area

associated with the UR3 shows bone remodeling (Figure 23). It can take up to 4 years for healing to occur fully (Torabinejad and Chivian 1999). The patient has been symptom free, the UR3 is not mobile, no pockets over 3 mm are evident, and there are no swellings or sinus tracts present. The overall prognosis for the UR3 is good.

DiscussionAt 1 year following loading, patient recall showed further bone regeneration in the UR2 area due to further functional remodelling (Figure 23). The co-author feels the need for the use of a particulate graft material in the repair of bone defects — not only to provide a scaffold for the bone regeneration but also for the up-regulation of the host response, with their use as shown in recent research that tested 38,000 genes (Zhao, et al., 2012). The patient’s oral hygiene was not ideal due to a reluctance to floss, but again no bleeding on probing was observed, and the patient had no adverse symptoms from the treatment. Healthy papillae were retained (Figure 24), although the need for improved OH was again stressed. The prognosis of root fractured teeth depends on the extent of the fracture line, the pulp tissue status, mobility of the coronal fragment, and dislocation of fragments (Andreasen, et al., 2004). Survival is poorest for root fractures located at the gingival third of the root (Welbury, et al., 2002). The UR3 was horizontally fractured at the junction of the middle and apical third of the roots. It was not mobile, and the coronal fragments did not appear dislocated; hence, the prognosis for treatment was good. The International Association of Dental Traumatology (IADT) guidelines (Flores, et al., 2007) recommend endodontic

Figure 21: Six months loaded showing retention of profileFigure 20: Abutment fitted — note new bone level Figure 22: Six months loaded with further improved bone levels

treatment only after pulp necrosis, not as a prophylactic intervention. Trauma cases should be carefully monitored clinically, radiographically, and with sensitivity tests (thermal, electric pulp testing). The treating practitioner should treat each case individually as no trauma case is the same. In this case pulpal necrosis developed, and endodontic treatment of the coronal fragment only was indicated, as root fractured teeth often possess a vital apical fragment even when the coronal fragment is necrotic (Andreasen and Hjorting-Hansen 1967; Hitchcock, et al., 1985; Cvek, et al., 2004). In the study by Cvek, et al., (2004), gutta percha was used to fill the root canal, and the authors found that overfilled root canal filling material between the fragments did not lead to healing. In this case healing was evident even though the root canal was overfilled; this could be because MTA was used instead of gutta percha. Radiological evaluation of root fractures is usually based on multiple periapical radiographs and occlusal views; however, with cone beam CT (the patient declined this), it is possible to examine the root in three dimensions, and this may aid in further assessment of the prognosis of the injured tooth.

Conclusion The result achieved for the patient has exceeded his expectations, with the use of newer materials and techniques having reduced both the treatment time scale as well as patient morbidity. These synthetic bone regeneration materials also negate the need for a material specific consent procedure, and their ability to “turnover” to host bone is often a vital factor in the patient consenting to the entire treatment plan as no remnant donor material (human or bovine) is present



REfEREncEs

Accorinte Mde L, Holland R, Reis A, Bortoluzzi MC, Murata SS, Dezan E Jr, Souza V, Alessandro LD. Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulp-capping agents in human teeth. J Endod. 2008;34:1-6.

Aeinechi M, Eslami B, Ghanbariha M, Saffar AS. Mineral trioxide aggregate and calcium hydroxide as pulp capping agents in human teeth: A preliminary report. Int Endod J. 2002;36:225-31.

Andreasen FM, Andreasen JO, Cvek M. Root fractures. In: Andreasen Jo, Andreasen FM, Andersson L(eds.):Textbook and color atlas of traumatic injuries to the teeth. Munksgaard, Kopenhagen. Wiley-Blackwell, 2007:337-371.

Andreasen JO, Andreasen FM, Mejare I, Cvek M. Healing of 400 intra-alveolar root-fractures: 1. Effect of pre-injury and injury factors such as sex, age, stage of root development, fracture type, location of fracture and severity of dislocation. Dental Traumatol. 2004;20:192-202.

Andreasen JO, Hjorting-Hansen E.Intraalveolar root fractures, radiographic and histology study of 50 cases. J Oral Surg. 1967;25:414-26.

Bornstein M, Hart C, Buser D et al.,. Early loading of nonsubmerged Titanium Implants with a chemically modified, sandblasted and acid-etched surface ; 6 month results of a prospective case series study in the posterior mandible, focusing on peri-implant crestal bone changes and Implant stability Quotient (ISQ) values. Clin Implant Dent Relat Res. 2009;11(4):338-47.

Brunette TM (2001). Titanium in Medicine. Springer 649-673.

Cvek M, Mejare I, Andreasen JO. Conservative treatment of teeth fractured in the middle or apical part of the root. Dent Traumatol. 2004;20:261-269.

Cvek M, Tsilingaridis G, Andreasen JO. Survival of 534 incisors after intra-alveolar root fracture in patients aged 7-17 years. Dental Traumatol. 2008;24:379-87.

Fairbairn P. Membrane-free guided bone regeneration. EDI Journal. 2011;7(3):74-80.

Felippe WT, Felippe MC, Rocha MJ. The effect of mineral trioxide aggregate on the apexification and periapical healing of teeth with incomplete root formation. Int Endod J. 2006;39:2-9.

Flores MT, Andersson L, Andreasen JO, Bakland LK, Malmgren B, Barnett F, et al.,. International Association of Dental Traumatology. Guidelines for the management of traumatic dental injuries. I. Fractures and luxations of permanent teeth. Dent Traumatol. 2007;23:66-71.

Gutta R, Baker R, et al.,. Barrier membranes used for ridge augmentation: is there an optimal pore size? J Oral Maxillofac Surg. 2009;67(6):1218-25.

Hitchcock R, Ellis E, Cox CF. Intentional vital root resection: a 52 week histopathologic study in Macaca Mulatta. J Oral Surg., Oral Med., Oral Path. 1985;60: 2-14.

Hunt JA, Cooper JJ (2012). The significance of zeta potential in osteogenesis. society for biomaterials , 31st meeting for biomaterials , Pittsburgh, PA 2006. 2012;592.

Lawley GR, Schindler WG, Walker WA, Kolodrubetz D. Evaluation of ultrasonically placed MTA and fracture resistance with intracanal composite resin in a model of apexification. J Endod. 2004;30:167-172.

Lee SJ, Monsef M, Torabinejad M. Sealing ability of a mineral trioxide aggregate for repair of lateral root perforations.0 1993;19:541-4.

Leventis M, Fairbairn P, Vasiliadis O et al.,. Socket Grafting using Beta Tri-Calcium Phosphate in a Calcium Sulfate matrix. EAO Poster, Copenhagen. 2012: 525.

Nair PN, Duncan HF, Pitt Ford TR, Luder HU. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial. Int Endod J. 2008;41:128-150.

Pace R, Giuliani V, Pin Prato L, Baccetti T, Pagavino G. Apical plug technique using mineral trioxide aggregate: results from a case series. Int Endod J. 2007; 40:478-484.

Pitt Ford TR, Torabinejad M, Abedi HR, Bakland LK, Kariyawasam SP. Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc. 1996; 127: 1491-4.

Podaropolous L, Vies A et al.,. Bone regeneration using Beta Tri-Calcium Phosphate in a Calcium Sulfate matrix, Journal of Oral Implantology 35(1):28-36.

Schenk RK. Bone regeneration: biologic basis. In: Buser D, Dahlin K, and Schenk RK, eds. Guided Bone regeneration in Implant Dentistry. London, UK: Quintessence; 1995:49-100.

Schropp L, Wenzel A, et al.,. Bone Healing and soft tissue changes following a single tooth extraction: A Clinical and radiographic 12 month study. Int J Periodontics Restorative Dent. 2003;23(4):313-23.

Simon S, Rilliard F, Berdal A, Machtou P. The use of mineral trioxide aggregate in one visit apexification treatment: a prospective study. Int Endod J. 2007;40:186-197.

Smeets R, Kolk A, et al., A new biphasic osteoinductive calcium composite material with a negative zeta potential for bone augmentation. Head & Face Medicine. 2009;13(5):13.

Torabinejad M, Chivian N. Clinical applications of mineral trioxide aggregate. J Endod. 1999;25:197-205.

Torabinejad M, Hong CU, McDonald F, Pitt Ford TR. Physical and chemical properties of a new root-end filling material. J Endod. 1995;21:349-353.

Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root-end filling material. J Endod. 1995; 19:591-595.

Welbury RR, Kinirons MJ , Day P, Humphreys K, Gregg TA. Outcomes for root-fractured permanent incisors: a retrospective study. Pediatr Dent. 2002;24: 98-102.

Zhao J, Watanabe T et al.,. Transcriptome analysis of BTcP implanted in a dog mandible bone. Elsevier. 2012;864-877.

Figures 24A and 24B: After 1 year of loading — needs more oral hygiene care

Figure 23: Radiograph at 1 year loaded — further bone improvement even in sites adjacent the canine

Figure 24A Figure 24B

in years to come. Material and technique advances in endondontics have also allowed us to

treat fractured roots, providing the correct protocols are initially followed. Accordingly, the patient’s desire for

a cost-effective, low-pain, and ethical solution have been met. IP

1. In the horizontally fractured tooth, ______usually occurs in the coronal fragment, while the pulp of the apical fragment remains vital.a. necrosis of the pulp b. calcium deficiencyc. residual boned. an access cavity

2. ______was developed in the 1990s as a root end filling material.a. Gutta perchab. Mineral trioxide aggregate (MTA) c. CaSO4 (calcium sulfate)d. Chlorhexidine

3. It (MTA) is associated with favorable apical healing when used as an apexification material in immature teeth with open apices because it ______, and is nonresorbable.a. encourages hard tissue formationb. is biocompatiblec. provides a good seal (prevents microleakage)d. all of the above

4. Guided bone regeneration is generally needed in trauma cases where dental implants are to be placed due to _____.a. mature root resorptionb. bone damage during the trauma

c. as a result of post-traumatic infectiond. both b and c

5. A delayed immediate placement protocol is the standard procedure where the tooth or root is removed carefully, so as to not damage the residual bone, and then left to heal for ___ week(s).a. 1b. 2c. 3 d. 4

6. Bone healing is further improved by not using a traditional (collagen-type) membrane that inhibits periosteal blood to the graft site, which accounts for ____ (or more) of the blood supply to the site.a. 50%b. 65%c. 85% d. 92%

7. The stability and soft tissue cell occlusive properties needed for successful bone regeneration are achieved by a ____element in the graft material; hence, the graft is its own membrane.a. MTAb. CaSO4

c. chlorhexidined. titanium

8. It is also noted that most particulate graft materials (Vital in particular) exhibit a _____ iso-electric charge in an aqueous solution, which attracts host bone morphogenetic proteins (BMPs) such as osteoponin and osteocalcin in greater numbers to the site.a. negative b. positivec. neutrald. stable

9. Once loaded, there appears to be little change in the profile in line with ____, in that function is essential to retain bone.a. Wolff’s Law b. Lambert-Beer’s lawc. Fresnel’s lawd. Bouger’s law

10. Trauma cases should be carefully monitored _____.a. clinicallyb. radiographicallyc. with sensitivity tests (thermal, electric pulp testing)d. all of the above

Multi-disciplinary approach to the treatment of traumatic root fracture: a case study

IMPLANT PRACTICE CEC

E C

RE

DIT

S

Each article is equivalent to two CE credits. Available only to paid subscribers. Free subscriptions do not qualify for the CE credits. Subscribe and receive up to 16 CE credits for only $99. To receive credit, complete the 10-question test by circling the correct answer, then either:

n Post the completed questionnaire to: Implant Practice US CE15720 N. Greenway-Hayden Loop. #9Scottsdale, AZ 85260n Fax to (480) 629-4002.

To provide feedback on this article and CE, please email us at [email protected]

Legal disclaimer: The CE provider uses reasonable care in selecting and providing accurate content. The CE provider, however, does not independently verify the content or materials. Any opinions expressed in the materials are those of the author and not the CE provider. The instructional materials are intended to supplement, but are not a substitute for, the knowledge, skills, expertise and judgement of a trained healthcare professional.

FULL NAME

AGD REGISTRATION NUMBER

LICENSE NUMBER

ADDRESS

CITY, STATE, AND ZIP CODE

EMAIL

TELEPHONE/FAX

REF: IP V7.1 FAIRBAIRN

Please allow 28 days for the issue of the certificates to be posted.

CONTINUING EDUCATION BROUGHT TO YOU BY

Approved PACE Program ProviderFAGD/MAGD Credit Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement12/1/2012 to 11/30/2016Provider ID# 325231


There is no doubt that the advent of dental implants is a revolution in

modern dentistry. In addition to fixed and removable prostheses supported by natural teeth, patients are now offered implants for replacement of their missing teeth. Without sacrificing tooth structure, implants resemble natural teeth in both function and esthetics. Thus, more and more implants have been placed in the past decades. Like the occurrence of periodontal disease or caries on natural teeth, however, the presence of peri-implant complications has been rising in recent years.

What are implant complications?From the authors’ point of view, implant complications can be categorized into three major types: biological, biomechanical, and esthetic implant complications. Similarly to periodontal disease, biological implant complications (ie, peri-implant diseases) present the inflammatory reactions on peri-implant tissues, including peri-implant mucositis, peri-implantitis, and implant loss. The primary etiologic factors of biological implant complications are bacterial pathogens and impaired host immune response. Besides these, multiple

Management of biological and biomechanical implant complications



Drs. Yung-Ting Hsu and Hom-Lay Wang summarize and reveal management protocols for implant complications

factors have been linked with the presence of biological implant complications, such as a history of periodontal disease, inadequate oral hygiene, and so on. Residual cement and smoking have also been reported as the risk factors (Mombelli and Decaillet 2011; 2013). On the other hand, mechanical overload is considered as the main cause of biomechanical implant complications (Misch, et al., 2005). Unlike natural teeth, dental implants contact supporting bone directly instead of the periodontal ligament (PDL). Without the cushion provided by the PDL, occlusal overstressing on dental implants tends to concentrate on crestal bone regions or implant prosthetic components and thereby causes biomechanical complications. Furthermore, other factors may also contribute to the occurrence of biomechanical overload, including inappropriate implant position, poor implant or prosthetic designs, and parafunction (Fu, et al., 2012; Hsu, et al., 2012). Even though the implant survival rate is high in general, the presence of implant complications is not rare. Previous studies reported the incidence of peri-mucositis was approximately 50% (Roos-Jansaker, et al., 2006; Rinke, et al., 2011). It is believed that this number was underestimated due to the reversibility of peri-mucositis (2013). For the complications caused by occlusal overload, Goodacre and co-workers reported several complications occurring in 1%-22% of implant-supported fixed prostheses (Goodacre, et al., 2003).

As for the occurrence of marginal bone loss, however, it varied from the definition/criteria used in different studies. Depending on the criteria, the prevalence of marginal bone loss ranged from 16.0%-36.6% (Roos-Jansaker, et al., 2006; Koldsland, et al., 2010). In fact, these data are suggesting that it is about time to face the challenges of peri-implant complications and learn how to properly manage them to better serve our professional, as well as the patients whom we are treating.

How to manage biological and biomechanical implant complica-tions?People say, “An ounce of prevention is worth a pound of cure.” To decrease the incidence of implant complications, it is important to have a comprehensive treatment plan and sound clinical performance both surgically and prosthetically. Regular implant maintenance is also essential after active therapy. Indeed, most of the implant biological complications are found during supportive therapy. The earlier the complication is diagnosed, the easier the clinician can fix the problem. The following section aims to suggest a flow chart about management of implant complications, which is summarized in Figure 1.

ExaminationDuring implant maintenance, a thorough examination is the first step to prevent the existing peri-implant complications getting

Yung-Ting Hsu, DDS, MSD, finished the residency program in graduate periodontics at University of Michigan (Ann Arbor, Michigan, USA) in 2013.

Hom-Lay Wang, DDS, MSD, PhD, is Collegiate Professor of Periodontics, Professor and Director of Graduate Periodontics at the University of Michigan. Dr. Wang has published more than 22 book chapters/invited reviews and more than 300 scientific articles. He serves as a chair of the Website Educational Committee for the Academy of Osseointegration, is a diplomate and a former co-chair and director of the American Board of Periodontology, and a fellow of American College of Dentists. He serves as an associate editor for JOMI, is a founding editorial board member for Clinical Advances in Periodontics, and an editorial board member on many other publications.

The authors do not have any financial interests, either directly or indirectly, in the products or information listed in the paper.

Educational aims and objectivesThe aim of this article is to present a clear explanation of and suggested treatment approaches for implant complications.

Expected outcomesCorrectly answering the questions on page 36, worth 2 hours of CE, will demonstrate the reader can:• Recognizethedifferencebetweenbiologicalandbiomechanical

complications.• Seehowtheypresentclinically.• Realizethecurrentconsensusontreatmentprotocols.

CO

NT

INU

ING

ED

UC

AT

ION


worse. The clinician can identify these complications by patients’ complaints, clinical examination, and radiographic assessment. Clinically, probing around implants with light force (0.25 N) using conventional probes is allowed and helpful to detect peri-implant diseases in the early stage (Etter, et al., 2002; Heitz-Mayfield, et al., 2013).Probing depth and bleeding on probing (BOP), as well as gingival color alteration, may indicate the changes of peri-implant health and the severity of disease. Checking occlusion and the integrity of prosthetic components is also helpful in recognizing possible biomechanical implant complications. Nevertheless, implant mobility is not considered as an effective indicator because it could only detect the differences in the late stage (2013). Besides, the changes to hard tissue can be investigated by using radiographic aids. Conventional radiographic examina-

tions, such as periapical films and vertical bitewings, are necessary for baseline and annual assessment. They can help discover the crestal bone level changes, or the presence of pathologic lesions. In spite of scattering effects, cone beam computed tomography (CBCT) scan may also provide the information for fenestration or dehiscence through its three-dimensional images. In some persistent cases of biological complications, clinicians and patients may benefit from microbiological analysis to select antibiotics adjunctive therapy.

DiagnosisAfter examination, accurate diagnosis is the next step that guides us toward the direction of treatment strategies. According to the recent American Academy of Periodontology (AAP) state-ment, peri-mucositis has been defined as an inflammatory reaction limited on soft tissue around implants, whereas peri-

implantitis infects both soft tissue and supporting bone (2013). The signs of peri-implant disease include BOP, gingival redness, and possible suppuration (Lang and Berglundh 2011). Biomechanical implant complications comprise the fracture or loosening of implant prosthetic components, early implant loss, and fracture of the implant body. Moreover, they share the same characteristics: progressive marginal bone loss, which may lead to implant loss in the late stage. For those implants without a radio-graphic baseline, peri-implantitis may be diagnosed if the marginal bone loss is ≥ 2 mm following biological bone remodeling (Sanz, et al., 2012). It should be kept in mind that the signs of both biological and biomechanical implant complications may be combined in the same lesions due to the presence of multiple etiologic factors.

• Clinical examinations (probing, BOP, exudate, occlusion, mobility ... etc )• Radiographic examination if needed (peri-apical films, vertical bitewing, and

CBCT scan)•Microbiological analysis

Examinations

Diagnosis• Fracture or loosening of implant/

prosthesis components•Marginal bone loss• Implant fracture

Biomechanical complications

Management

Remove etiological factors and control contributing factors, including occlusal equilibration

For fracture or loosening of implant/prosthesis components

• Retighten or replace the component

•Occlusal bite splint delivery

For tissue reaction and/ormarginal bone loss

• Non-surgical therapy• Surgical therapy•Regenerativesurgery•Resectivesurgeryplus

implantoplasty• Adjunctive therapy: laser,

antibiotics•Occlusal bite splint delivery

For severe marginal bone loss (> 1/2 implant length), loss of osseointegration or implant

• Implant removal

Regular maintenance

Figure 1: Management of biological and mechanical implant complications

• Tissue reactions: Peri-implant mucositis or peri-implantitis

• Loss of osseointegration

Biological complications



ManagementRemoval of etiologic factors and control of contributing factors are essential to stop disease progression. In other words, eliminating biofilms and related risk factors are the primary goal when treating biological implant complications. In addition to adequate home/professional care and controlled systemic disease, smoking cessation should be discussed with patients prior to implant therapy. For peri-implant mucositis, it is believed that non-surgical therapy using mechanical debridement is capable of controlling the inflammation and reducing probing pocket depth (Porras, et al., 2002;Trejo, et al 2006). Non-surgical therapy also includes laser treatment and chemical antimicrobial agents (Heitz-Mayfield, et al., 2013). As for the management of biomechanical implant complications, finding and removing the source of overstress are essential (Kim, et al., 2013). Occlusal equilibration should be done prior to retightening the loosening prosthesis/abutment screw. The fracture prosthetic components should be replaced

or repaired. Besides, occlusal bite splint is highly recommended for patients suffering from parafunction (Hsu, et al., 2012). Treatment strategies vary in the management of marginal bone loss, depending on the morphology and severity of bony destruction. For minor bony destruction (i.e., vertical bone loss ≤ 2 mm), non-surgical therapy, including adjunctive therapies, is recommended. Instead, surgical therapy is more effective in the treatment of bony destruction > 2 mm where that is still less than half of implant fixture length. Similarly to periodontal defects, regenerative surgery should only be considered for 2- or 3-wall intrabony defects. Meanwhile, osseous resective surgery and implantoplasty are suggested for those defects presenting suprabony or non-regenerative destruction (Okayasu and Wang 2011; Muthukuru, et al., 2012; Renvert, et al., 2012). If occlusal overload contributes to the marginal bone loss, occlusal splint should be considered after correction of occlusal problems (change/modification of implant prosthesis or selective occlusal adjustment).

Figure 2: The presence of peri-implant complications on the LL5 implant-supported crown with cryonic peri-implant mucosa as well as the presence of BOP and exudate

In addition to conventional methods, various adjunctive therapies have been suggested in the treatment of peri-implantitis to decontaminate the implant surface, such as chemical, mechanical, and laser treatments and photodynamic therapy (PDT). A recent meta-analysis suggested that the use of local antibiotic delivery brought minor but significant improvement in the treatment of peri-implantitis (Muthukuru, et al., 2012). On other hand, the adjunctive benefits of systemic antibiotics have not been investigated (Renvert, et al., 2012). Laser therapy has also been used for the decontamination of the implant surface. Nevertheless, the efficacy has not been confirmed in either non-surgical or surgical treatments (Meyle 2012; Renvert, et al., 2012). Implant removal should also be kept in mind as an option in the treatment of severe implant complications. For example, those implants with loss of osseointegration should be removed as soon as possible to prevent further inflammation and tissue loss. In implants with severe bony destruction — of more than 1/2 of implant length — or placed in inappropriate positions, removing

Figure 3: The presence of peri-implant complications with marginal bone loss

Figure 4: After flap reflection, an infrabony defect on buccal aspect of the implant was noticed

Figure 5: Regenerative therapy was performed using allograft and collagen membrane

Figure 6: Postoperative outcome at 3 months after surgery. Significant bone fill of the infrabony defect was noticed

Figure 7: Postoperative outcome at 6 months after surgery. The postoperative crestal bone level remains stable

REfEREncEs

Clem DS, Cochran DL, Froum SJ, McAllister BS, RenvertS,RosenPS,WangH-L.AmericanAcademyofPerioodntologyReport.Peri-implantmucositisand peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013;84(4): 436-443.

Aljateeli M, Fu JH, et al. Managing peri-implant bone loss: current understanding. Clin Implant Dent Relat Res. 2012;14(Suppl 1):e109-118.

EtterTH,HakansonI,etal.Healingafterstandardizedclinical probing of the perlimplant soft tissue seal: a histomorphometric study in dogs. Clin Oral Implants Res. 2002;13(6):571-580.

Fu JH, Hsu YT, et al.. Identifying occlusal overload and how to deal with it to avoid marginal bone loss around implants. Eur J Oral Implantol. 2012;5(Suppl): S91-S103.

Goodacre CJ, Bernal G, et al. Clinical complications with implants and implant prostheses. J Prosthet Dent. 2003;90(2):121-132.

Heitz-MayfieldLJ,NeedlemanI,etal.ConsensusStatementsandClinicalRecommendationsforPrevention and Management of Biologic and Technical Implant Complications. Int J Oral Maxillofac Implants. 2013 Aug 15.

Hsu YT, Fu JH, et al. Biomechanical implant treatment complications: a systematic review of clinical studies of implants with at least 1 year of functional loading. Int J Oral Maxillofac Implants. 2012; 27(4):894-904. Kim Y, Oh TJ, et al. Occlusal considerations in implant therapy: clinical guidelines with biomechanical rationale. Clin Oral Implants Res. 2005;16(1):26-35.

Koldsland OC, Scheie AA, et al. Prevalence of peri-implantitis related to severity of the disease with different degrees of bone loss. J Periodontol. 2010; 81(2): 231-238.

LangNPandBerglundhT.Peri-implantdiseases:where are we now? Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011;38(Suppl 11):178-181.

Meyle J. Mechanical, chemical and laser treatments of the implant surface in the presence of marginal bone loss around implants. Eur J Oral Implantol. 2012;5 (Suppl): S71-S81.

MischCE,SuzukiJB,etal.Apositivecorrelationbetween occlusal trauma and peri-implant bone loss: literature support. Implant Dent. 2005;14(2):108-116.

Mombelli A and Decaillet F (2011). The characteristics of biofilms in peri-implant disease. J Clin Periodontol 38 (Suppl 11):203-213.

MuthukuruMA,ZainviA,etal.Non-surgicaltherapyfor the management of peri-implantitis: a systematic review. Clin Oral Implants Res. 2012;23 (Suppl 6):77-83.

Okayasu K and Wang HL. Decision tree for the management of peri-implant diseases. Implant Dent. 2011;20(4):256-261.

PorrasR,AndersonGB,etal.Clinicalresponseto2different therapeutic regimens to treat peri-implant mucositis. J Periodontol. 2002;73(10):1118-1125.

RenvertS,PolyzoisI,etal.(2012).Surgicaltherapyfor the control of peri-implantitis. Clin Oral Implants Res. 2012;23(Suppl 6):84-94.

RinkeS,OhlS,etal.Prevalenceofperi-implantdisease in partially edentulous patients: a practice-based cross-sectional study. Clin Oral Implants Res. 2011;22(8):826-833.

Roos-JansakerAM,LindahlC,etal.Nine-tofourteen-year follow-up of implant treatment. Part II: presence of peri-implant lesions. J Clin Periodontol. 2006; 33(4):290-295.

Trejo PM, Bonaventura G, et al. Effect of mechanical and antiseptic therapy on peri-implant mucositis: an experimental study in monkeys. Clin Oral Implants Res. 2006;17(3): 294-304.

CO

NT

INU

ING

ED

UC

AT

ION


the implant is a good option instead of saving implants with uncontrolled infection (Okayasu and Wang 2011; Aljateeli, et al., 2012). In around 1% of cases presenting biomechanical implant complications, implant removal is the only option to treat implant body fracture (Hsu, et al., 2012).

Case reportThis 50-year-old female, who is a former smoker, presented for implant maintenance. The implants were placed on the LL5 and LL6 about 6 months ago. She reported the tenderness of peri-implant mucosa starting from a couple of weeks after the implant-supported crown delivery. In addition to localized gingival redness (Figure 2), the probing depth was 7 mm on buccal and distobuccal aspects of the LL5 implant with BOP and exudate discharge. Periapical film also showed marginal bone loss (Figure 3). Fortunately, there was no premature contact or signs of overloading when checking occlusion. This lesion was thus diagnosed as a biological implant complication. To treat a peri-implant defect with >2 mm vertical bone loss, surgical therapy was planned. Due to the defect morphology (Figure 4), regenerative surgery was performed using allograft (enCore® mineralized allograft, Osteogenics Biomedical) and a collagen membrane (Pericardium, Zimmer Dental Inc.) (Figure 5). Significant regeneration was found at 3 months and 6 months post-operatively (Figures 6 and 7). After 6 months healing, the peri-implant mucosa returned to healthy status without BOP or exudate (Figure 8).

ConclusionIn conclusion, treatment strategies of peri-implant complications should be chosen based upon each individual case scenario.

Comprehensive examinations together with accurate diagnoses are essential for the successful management of implant complications. In spite of the complexity of the treatments, the prime objective of the treatment is to eliminate/control the etiologic factors and the contributing factors. Depending on the severity of diseases, various approaches are available to manage biological implant complications, including non-surgical mechanical/chemi-cal debridement, regenerative surgery, and resective surgery with or without implantoplasty. Adjunctive therapies, such as antibiotics and laser, may be helpful in certain cases. Meanwhile, occlusal equilibration should be achieved when treating biomechanical implant complications. Following repair or replacement of implant/

Figure 8: Postoperative outcome at 6 months after surgery. Peri-implant mucosa returned to healthy status without BOP or exudate

prosthetic components, clinicians need to consider the occlusal bite splint therapy as a proactive precaution. Nevertheless, implant removal should always be an option when the destruction is too severe to be repaired. With the increasing need for implant placement, the occurrence of peri-implant complications is becoming a worldwide challenge. As implantologists in a new era, clinicians should have the knowledge of implant therapy, as well as associated peri-implant complications. More research is needed to further investigate peri-implant complications and their management. With the changing of these treatment approaches, it should be borne in mind that “a disease known is half-cured.”

This paper was partially supported by the University of Michigan Periodontal Graduate Student Research Fund.

IP

1. Similarly to periodontal disease, biological implant complications (ie, peri-implant diseases) present the inflammatory reactions on peri-implant tissues, including _______.a. peri-implant mucositisb. peri-implantitisc. implant lossd. all of the above

2. The primary etiologic factors of biological implant complications is(are) _____.a. bacterial pathogensb. impaired host immune responsec. biomechanical overloadd. both a and b

3. Unlike natural teeth, dental implants contact supporting bone _____instead of the periodontal ligament (PDL).a. directlyb. indirectlyc. incidentallyd. inadequately

4. Without the cushion provided by the PDL, occlusal overstressing on dental implants tends to concentrate on crestal

bone regions or implant prosthetic components and thereby causes ____.a. pathogenic reactionsb. biomechanical complicationsc. residual cementd. peri-implantitis

5. Even though the implant survival rate is high in general, the presence of implant complications is not rare. Previous studies reported the incidence of peri-mucositis was approximately ____.a. 25%b. 35%c. 50%d. 75%

6. During implant maintenance, _____is the first step to prevent the existing peri-implant complications from getting worse. a. a thorough examinationb. frequent radiographsc. fenestrationd. premedication

7. ______ is also helpful in recognizing possible biomechanical implant complications.

a. Tomogramsb. Checking occlusionc. Checking integrity of prosthetic componentsd. Both b and c

8. The signs of peri-implant disease include _____.a. BOP (bleeding on probing)b. gingival rednessc. possible suppurationd. all of the above

9. Occlusal equilibration should be done _____retightening the loosening prosthesis/abutment screw.a. afterb. prior toc. duringd. instead of

10. In around ___ of cases presenting biomechanical implant complications, implant removal is the only option to treat implant body fracture. a. 1%b. 5%c. 10%d. 15%

Management of biological and biomechanical implant complications

IMPLANT PRACTICE CEC

E C

RE

DIT

S

Each article is equivalent to two CE credits. Available only to paid subscribers. Free subscriptions do not qualify for the CE credits. Subscribe and receive up to 16 CE credits for only $99. To receive credit, complete the 10-question test by circling the correct answer, then either:

n Post the completed questionnaire to: Implant Practice US CE15720 N. Greenway-Hayden Loop. #9Scottsdale, AZ 85260n Fax to (480) 629-4002.

To provide feedback on this article and CE, please email us at [email protected]

Legal disclaimer: The CE provider uses reasonable care in selecting and providing accurate content. The CE provider, however, does not independently verify the content or materials. Any opinions expressed in the materials are those of the author and not the CE provider. The instructional materials are intended to supplement, but are not a substitute for, the knowledge, skills, expertise and judgement of a trained healthcare professional.

FULL NAME

AGD REGISTRATION NUMBER

LICENSE NUMBER

ADDRESS

CITY, STATE, AND ZIP CODE

EMAIL

TELEPHONE/FAX

REF: IP V7.1 WANG

Please allow 28 days for the issue of the certificates to be posted.

CONTINUING EDUCATION BROUGHT TO YOU BY

Approved PACE Program ProviderFAGD/MAGD Credit Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement12/1/2012 to 11/30/2016Provider ID# 325231


MDI Mini Dental Implants

3M and ESPE are trademarks of 3M or 3M Deutschland GmbH. Used under license in Canada. © 3M 2013. All rights reserved.

3M ESPE Customer Care: 1-800-634-2249

MDI Certification Seminar — 7 CE Credits

DAY 1: Learn how market leading 3M ESPE MDIs can help you offer a solution to patients who may be contra-indicated for conventional implant treatment. The focus of this seminar is on the surgical placement protocol and full dentures. Includes hands-on experience.

MDI Expanded Indications Training Seminar — 7 CE Credits

DAY 2: Build on your knowledge from the certification course with the focus on:

• Removable partial dentures, maxillary dentures and single tooth restorations

• Addressing challenging cases

This course is for doctors who have completed the certification course or have experience placing mini implants.

Certification Seminar Tuition: $695; Expanded Indications Training Seminar Tuition: $495; or Both for $995

Learn how to effectively integrate 3M™ ESPE™ MDI Mini Dental Implants into your practice by attending the seminar that best meets your needs. Attend one or both days.

Building doctors’ practices.Changing patients’ lives.

2014 MDI Certification and Expanded Indications Training Seminars

Event Seminar Date LocationDay 1 Certification Jan. 24 Nashville, TNDay 1 Certification Jan. 29 Boston, MADay 1 Certification Jan. 31 Houston, TXDay 1 Certification Feb. 19 Chicago, IL

Day 1 Certification Feb. 21 San Diego, CADay 2 Expanded Feb. 22 San Diego, CA

Day 1 Certification Feb. 21 Kansas City, MODay 2 Expanded Feb. 22 Kansas City, MO

Day 1 Certification Feb. 28 Charlotte, NCDay 1 Certification Feb. 28 Columbus, OHDay 2 Expanded Mar. 1 Columbus, OH

Day 1 Certification Mar. 8 Des Moines, IADay 1 Certification Mar. 14 Las Vegas, NVDay 2 Expanded Mar. 15 Las Vegas, NV

Day 1 Certification Mar. 21 Seattle, WADay 2 Expanded Mar. 22 Seattle, WA

Day 1 Certification Mar. 28 Minneapolis, MNDay 2 Expanded Mar. 29 Minneapolis, MN

Day 1 Certification April 4 Detroit, MIDay 1 Certification April 4 Denver, CODay 1 Certification April 4 Jacksonville, FLDay 1 Certification April 11 Pittsburgh, PADay 1 Certification April 11 Denver, CODay 2 Expanded April 12 Denver, CO

For more information or to enroll today visit

3MESPE.com/ImplantSeminars

Having the ability to take a patient from point A-Z in a fewer amount of

appointments within your practice allows you to position yourself as a provider who can fulfill your patient’s surgical and restorative needs. With the proper training, a dental provider may provide extraction, grafting, and implant placement within one appointment at one location. Not only does this allow you to reduce the amount of visits for the patient, but this type of service also helps stay within the patient’s budget. Most importantly, this enables the dental provider full control of the surgical and prosthetic outcome. Depending on the patient’s desires, the clinical conditions of the oral environment present, and the skills of the provider, a dentist may choose to extract teeth, level bone, and graft with simultaneous dental implant placement. A patient in his mid-60s presented to the office with discomfort due to multiple rampant caries and generalized advanced periodontal disease (Figures 1 and 2). Having already visited multiple providers for a consultation, he was very frustrated with the treatment options offered due to varying treatment plans that were segmented by different disciplines. Since many of these options did not complement the other, the patient decided to come to us for full treatment (A-Z) after being referred to us by one of our patients who had already undergone a Total Dental Solutions Reconstruction™. Before the surgical appointment, a CBCT scan was taken to accurately treatment plan this case to make certain

that no complications would arise from doing all the procedures (extract, graft, and implant placement) in the Total Dental Solutions Reconstruction protocol. SimPlant® software (Materialise Dental, Glen Burnie, Maryland) was used through 3D Diagnostix virtual assistance to precisely plan the placement of six Engage™ (OCO Biomedical) dental implants in the maxillary arch, as well as seven Engage dental implants in the mandibular arch, using CT-based surgical pilot guides (Figure 3 and 4). The final treatment plan desired was fixed bridges on implants in the upper and lower arches. Engage dental implants were selected (Figure 5) because I have personally experienced their high implant stability at placement, which is a critical success factor during the early healing process of osseointegration with these types of cases. With the combination of their patented Bull Nose Auger™ tip and Mini Cortic-O Thread™, the Engage (OCO Biomedical) implant system offers practitioners a bone level implant with high initial stability

for selective loading options. In fact, the Engage (OCO Biomedical) implant body creates a tapping pattern when threaded for an enhanced mechanical lock in the bone. Other dental implant systems with aggressive threading may include but are not limited to NobelActive (Nobel Biocare®), Seven (MIS), ETIII (Hiossen), I5 (AB Dental USA), and AnyRidge® (Megagen). In order to be effective and more proficient during these Total Dental Solutions Reconstruction procedures, I will utilize IV sedation. Not only does it make the appointment easier for me, but also patients prefer to get everything done in one visit. Since they are sedated, a mouth prop is needed to keep their mouth open. Because of this, I will routinely extract teeth in quadrants starting from the upper left to the upper right and then down to the lower right and lower left. This allows great time savings as it is easier to keep the patient’s mouth open and be able to proceed around the arches safely. Once the teeth are extracted, I will reflect the tissue in order to get the bone

Advanced technologies and materials to efficiently deliver full mouth reconstructions


TECHNOLOGY

Dr. Ara Nazarian suggests a treatment solution that results in more control and fewer appointments

Figure 1: Retracted preoperative view

Ara Nazarian, DDS, DICOI, maintains a private practice in Troy, Michigan, with an emphasis on comprehensive and restorative care. He is a Diplomate in the International Congress of Oral Implantologists (ICOI). His

articles have been published in many of today’s popular dental publications. Dr. Nazarian is the director of the Reconstructive Dentistry Institute. He has conducted lectures and hands-on workshops on esthetic materials and dental implants throughout the United States, Europe, New Zealand, and Australia. Dr. Nazarian is also the creator of the DemoDent patient education model system. He can be reached at (248) 457-0500 or at the website www.aranazariandds.com

Figure 2: Preoperative panorex

Figure 3: Maxillary virtual treatment plan Figure 4: Mandibular virtual treatment plan

Early? Or delayed loading?Resonance Frequency Analysis as a technique to

measure implant stability and osseointegration is fast

becoming a global diagnostic standard. With more

than 500 articles published in scientific journals it is

a proven scientific method as a guide to predictable

surgical and restorative protocols.

Manage implants at risk - You’ll find Osstell ISQ

especially valuable for achieving more predictable

outcomes when treating higher risk patients and

implants at risk for failure due to poor integration.

Osstell gives you an early warning, as a decreased ISQ

value, if osseointegration isn’t progressing as expected.

It can help you avoid costs of an implant failure or

redoing a crown due to premature loading. Osstell can

also assist you in being more confident about treating

www.osstell.com

Your guide to Predictable surgical and restorative protocols

One? Or two stage?Immediate?

Visit Osstell at the ICOI Winter Symposium - Jan 16 – 18 - New Orleans, LA - booth #507

patients with risk factors, more predictably.

Reduce treatment time - If the initial mechani-

cal stability is high enough a one-stage approach

is often used together with immediate- or early

loading. By measuring again before the final restora-

tion, and comparing that value to the baseline value

taken at placement, the decision whether to proceed

or not is made quick and easy.

With Osstell as a part of your quality assurance

system it’s also easier to explain treatment planning

and healing time to your patients and colleagues.

Now Osstell brings you and

your patient new certainty.

Shop on-line at


TECHNOLOGY

level surgical guides seated and fixed with their respective retention pins. Using these pilot surgical guides provided by 3D Diagnostix, the sites for the implants were begun with a 1.95 mm pilot drill utilizing the Mont Blanc surgical handpiece and Aseptico surgical motor (AEU 7000) at a speed of 1200 rpm with copious amounts of sterile saline (Figures 6 and 7). Paralleling pins were placed in the sites of the osteotomies to confirm the accuracy of the surgical guide, and X-rays were taken to check the angulations of the pins within the maxilla and the mandible. Once the osteotomies were complete, an implant finger driver was used to place the Engage dental implants until increased torque was necessary. The ratchet wrench was then connected to the adapter, and the implants torqued to final depths reaching a torque level of about 50-60 Ncm. Adequate implant fixation was further verified using an Osstell® implant stability quotient (ISQ) implant stability meter (Osstell), which uses resonance frequency analysis as a method of measurement (Figure 8). Several studies have been conducted based on resonance frequency analysis (RFA) measurements and the ISQ scale. They provide valid indications that the acceptable stability range lies above 55 ISQ. Extended healing caps were hand-tightened to the implants. A postoperative radiograph was made of the implants and the healing caps to ensure complete seating. The immediate dentures were soft relined with a silicone-based soft denture relining material Ufi Gel SC (VOCO

America). Some of the advantages I have personally experienced with this material are that it is biocompatible, tasteless, and odorless. By using the extended healing caps with the soft reline, the immediate dentures were much more retentive. The soft tissue and implants were evaluated clinically after 1 week. The patient stated he had very little postoperative discomfort or swelling. Within 10 days, the patient returned to the dental office. The soft tissue around the extended healing caps healed very nicely with a healthy pink color. Using impression posts, full arch impressions were taken using Instant Custom C&B Trays (Goodfit). These custom trays can be adapted and fitted in minutes, eliminating the need for models, light cure materials, monomers, and extra laboratory time in custom impression tray fabrication because they are made of a material, polymethyl methacrylate (PMMA), that becomes adjustable when heated (Figure 9) and maintains its shape while cooling. Once molded for the patient, full arch impressions were taken using a polyvinylsiloxane impression material (Take 1® Advanced, Kerr®) (Figure 10). Bite relations, as well as instructions for size, shape, and color for full arch provisionals, were forwarded to the dental laboratory. With only a 5-day turnaround, the custom abutments and provisionals were forwarded to the dental office and inserted. The patient was very pleased with the esthetics and function of these provisional restorations. He was instructed about their care and use in

eating, speaking, and biting. Approximately 4 months after the initial placement of the dental implants, the patient returned for the definitive porcelain fused to metal restoration impressions. The provisional restorations were removed using the Pneumatic Crown and Bridge Remover (DentCorp). Any temporary cement was removed and the abutments inspected. If there was any settling or recession of the gingival tissue, the abutments were modified using a carbide bur with copious amounts of water so as not to overheat the abutments. This way, the margins could be brought right at or slightly below the free gingival marginal area. A full arch impression was taken in a similar fashion for the abutments and the provisionals. In addition, the relations between maxillary and mandibular arches were captured. Within 3 weeks, the porcelain fused to metal restorations were inserted and a panorex taken (Figures 11 and 12). More and more patients are presenting to dental practices requiring this type of reconstruction. By providing multiple services in a shorter number of visits with the use of CBCT and other technologies, you, the dental provider, will find more patients who will accept treatment. In doing so, you are not only helping your patients get to proper form and function, but also helping them achieve a Total Dental Solutions Reconstruction in a fewer amount of appointments.

Figure 7: Using pilot guide Figure 8: Osstell® ISQ unit

Figure 9: Goodfit Instant Custom C&B Tray Figure 10: Full arch impression Figure 11: Retracted postoperative view Figure 12: Postoperative panorex

Figure 5: Engage™ dental implant Figure 6: Aseptico surgical motor

IP

©2013 Zimmer Dental Inc. All rights reserved. * Data on file with Zimmer Dental. Please check with a Zimmer Dental representative for availability and additional information.

www.zimmerdental.com

I am the Zimmer® Trabecular Metal™ Dental Implant, the first dental implant

to offer a mid-section with up to 80% porosity—designed to enable bone INGROWTH as well and

ONGROWTH. Through osseoincorporation, I harness the tried-and-true technology of Trabecular Metal

Material, used by Zimmer Orthopedics for over a decade. My material adds a high volume of ingrowth

designed to enhance secondary stability.... and I am Zimmer.

Osseoincorporation

Trabecular Metal Material

Trabecular bone

Bone Ongrowth + Bone In

grow

th*

Artistic Rendering

THE BEST THING

NEXT TO BONE™

Visit TrabecularMetal.zimmerdental.com to view a special bone ingrowth animation and request a Trabecular Metal Technology demo.

IntroductionMany events may lead to the loss of native oral bone. These include trauma, developmental anomalies, pathological processes (acute and chronic), and tooth loss.1-3 When alveolar bone resorption occurs, the residual hard tissue may be insufficient to support dental implants. Alternatively, implants may be placed, but the dearth of bone may lead to improper positioning, compromising the definitive restoration. Improperly positioned implants are associated with biomechanical concerns (screw loosening, fractures of the screw, implant, implant collar, prosthesis, or porcelain)4-6 as well as poor screw-access positioning and unnatural emergence profiles. A variety of bone-augmentation strategies have been developed to avoid such problems and enable dentists to accurately recreate natural dental function and esthetics. Onlay, inlay, and veneer grafts,7-9 sinus augmentation,10-12 ridge splitting and expansion,13,14 guided bone regeneration,15-19 nerve lateralization,20 and distraction osteogenesis21 all have a documented record of success when used to treat horizontally and vertically atrophic ridges, extraction sockets, implant-associated defects, and other anatomical deficiencies. Most of these techniques require the use of bone-grafting materials. Autografts, allografts, xenografts, and alloplasts all have been documented to be successful, used either alone or in combination. Among them, autogenous bone has long been considered the gold standard. Depending upon the donor site and the manner in which it is harvested, autogenous bone has proven to be osteoconductive, osteoinductive, and nonantigenic — all

properties of an ideal grafting material. However, the use of autogenous bone also has been associated with a number of disadvantages, including patient morbidity, parasthesia, anesthesia, and neurosensory changes to the proximal teeth and tissue, edema, ptosis, incision dehiscence, and infection.8,22-25 Implants placed in autogenous block grafts have been associated with lower survival rates,26 and significant resorption has been reported.7,27-30

Allograft bone, commercially available in a variety of sizes, shapes, and process-ing techniques, is an alternative to autogenous material. Successful results from using allografts have been reported in the periodontal and implant-regenerative literature for more than three decades.31 Moreover, using this material enables patients to avoid having a second surgical site. The question of whether freeze-dried

bone allograft (FDBA) or demineralized freeze-dried bone allograft (DFDBA) is superior for regeneration has generated some controversy. Successes with both have been documented in case reports, and when used primarily in intraosseous defects, significant clinical differences between the two materials have not been found.19,32-34 However, DFDBA historically has been considered to be a better choice in challenging regenerative sites because of the demineralization process. Urist has described35 how this process bathes the allograft in an acidic solution, thereby exposing the bone-morphogenetic proteins, which theoretically render it osteoinductive. When used in dental applications in combination with a barrier membrane, clinical results of DFDBA grafts in both humans and animals have varied signifi-cantly,36-39 and the osteoinductivity of the DFDBA has come into question. The varia-

Verified osteoinductive allograft putty for dental implant regeneration: preliminary findings of three clinical applications


TECHNOLOGY

Dr. John Lupovici illustrates clinical cases using RegenerOss® Allograft Putty to regenerate three distinct osseous defects

Figure 1: Initial occlusal view of the extraction socket of the mandibular first molar

John Lupovici, DDS, is a Diplomate of the American Board of Periodontology and a faculty member at the New York University College of Dentistry Department of Periodontics.

Figure 2: Post-extraction alveolus filled with osteoinductive graft material

Figure 3: Occlusal view of the regenerated site 3 months after extraction and grafting

Figure 4: The implant was placed in the newly regenerated bone adjacent to the biopsy core harvest site.

for as low as

*$276 per month!

®Own the New Piezosurgery

*On Approved Credit - US Dentists only - Special 3.98% Interest Arrangement with Highland Capital Corp.


TECHNOLOGY

tion in clinical results has been linked to a number of potential factors, including ster-ilization techniques,40-41 particle size,42 and donor age.43 The processing techniques of individual bone banks also may affect the inductive capacity of the bone.44,45

RegenerOss® Allograft Putty (Biomet 3i, Palm Beach Gardens, Florida) is an allograft material that was used for a long time in orthopedics before recently being adapted for oral and maxillofacial grafting applications. It presents in putty form, consisting of osteoinductive DFDBA (40% by weight) suspended in lecithin, an organic phosphatidylcholine. The DFDBA in RegenerOss Allograft receives routine screening for HIV, hepatitis, and other infectious agents. Furthermore, the Saos cell-proliferation test is used to verify the osteoinductivity of every sample. Results of this assay have demonstrated a correlation coefficient of 0.850 (p < 0.0005) with implantation of demineralized bone into athymic rat muscle.46

Although one aspect of the process-ing technique for removing lipids from de-mineralized bone has been found to inhibit osteoinduction significantly, adding purified lecithin to the DFDBA appears to restore the osteoinductive activity and enhance biological activity above that of a standard demineralized bone preparation.47 Naturally present in cell membranes, tissues, and or-gans, lecithin is believed to play an active role in the biologic calcification that occurs during osteogenesis.48

Clinical benefits of the lecithin carrier include the fact that, as a lipid, it is hydrophobic, offering high resistance to irrigation, blood, and saliva. It provides remarkable ease of handling and excellent graft containment after being exuded into the defect site. When incubated at 37°C, the putty maintains a solid state and remains intact at the graft site for 7 to 14 days, after which it is absorbed by the body with no foreign-body reaction. Autogenous or other additional bone-grafting material easily can be combined with it, should that option be desired. Other commercially available allograft putties use glycerol as a binding agent, and hence, may pose concerns over toxicity. The following clinical cases illustrate the use of RegenerOss Allograft Putty to regenerate three distinct osseous defects.

Case PresentationsCase No. 1This 47-year-old, systemically healthy fe-male patient presented with a periodontally

hopeless mandibular right first molar. Following administration of local anesthesia (Lidocaine with epinephrine 1:100,000), the molar was sectioned, and the mesial and

Figure 5: Three-month histology of newly formed bone, in association with residual graft material. A large degree of trabeculation is evident. Original magnification x10

Figure 6: Six-month histology sample displaying new bone and vasculature, with a reduction in medullary space. Original magnification x10

Figure 7: High-power magnification of 6-month sample displaying blood vessel. Original magnification x40

distal roots were atraumatically elevated from the alveolus (Figure 1). Care was taken to avoid traumatizing the alveolus. All granulation tissue was carefully curetted from the socket, which then was filled with the inductive allograft putty (Figure 2). A 2-mm thick slice of a collagen wound dressing material was placed over the graft to better contain the putty. The tissues were sutured, and no attempt was made to achieve primary closure. The patient received antibiotic therapy consisting of Amoxicillin 250 mg 3 times a day for 1 week. The regenerated area remained unloaded throughout the healing process. The patient returned for postoperative evaluation at 1, 3, 6, and 12 weeks postoperative. Soft-tissue healing was uneventful. Three months after the extraction and augmentation, the patient presented for implant placement. Intraoral examination revealed successful maintenance of the alveolar ridge width. Following administration of anesthesia, a full-thickness flap was reflected, and the preservation of the hard tissue was confirmed (Figure 3). A 3 mm trephine histology core was harvested on the mesial aspect of the graft site. This specimen was immediately fixed in 10% neutral buffered formalin for later histological preparation and examination. The osteotomy created by harvesting

the trephine core was enlarged, and the bone quality was noted to be Type 2-3, according to the Lekholm and Zarb scale. A parallel-walled implant was placed (Figure 4), and primary stability was verified. The tissues were then sutured, and primary closure was achieved. Three months after implant placement, osseointegration was verified radiographi-cally. A full-thickness flap was reflected to enable placement of a healing abutment. To accommodate this, removal of a 1 x 2 mm wedge of augmented bone from the distal aspect of the previously regenerated socket was found to be necessary. The harvested bone was immediately stored in 10% neutral buffered formalin for later histologic examination.

Histological processing and examination Both samples were dehydrated in increasing grades of ethanol and subsequently infiltrated with resin. After being embedded in methylmethacrylic resin, the samples were polymerized and sectioned vertically using a cutting-grinding unit. The 250-µm thick units obtained were further reduced by microgrinding and polishing to a final thickness of about 20-30 µm. The sections were stained with hematoxylin and eosin, and examined under a light microscope equipped with an image system. The histologic section obtained at 3

months revealed newly formed bone and minimal residual graft material. The residual graft particles that were present were in close contact with bone or connective tis-sue. The new lamellar bone appeared vital with osteocytes in the lacunae (Figure 5). The histology sample obtained at 6 months displayed further new bone and vasculature with a reduced presence of residual graft material as well as medulary space. No histologic signs of inflammation were present in any of the sample slices (Figures 6 and 7).

Case No. 2The patient was a 54-year-old male who presented for full-mouth rehabilitation with fixed, implant-retained restorations. His medical history was unremarkable. The antibiotic regime described above was administered. A crestal incision of one edentulous mandibular segment was made, and reflection of a full-thickness gingival flap revealed the horizontal dimension of the residual alveolar ridge to be approximately 4-5 mm. Two implants were placed according to the manufacturer’s protocol, and primary stability was achieved for both. However, a buccal dehiscence defect exposed four threads on the facial aspect of the mesial implant (Figure 8). RegenerOss Allograft Putty was applied to the dehiscence to cover the

TE

CH

NO

LOG

Y


Figure 8: A buccal dehiscence defect exposed four threads on the facial aspect of the mesial implant

Figure 9: Osteoinductive allograft putty was applied to cover the residual threads

Figure 10: A biologic membrane was adapted over the graft material

Figure 11: Intraoperative view of the newly regenerated bone 5 months after grafting

Figure 12: A full-thickness mucoperiosteal flap was reflected, and the maxillary right central incisor and left lateral incisor were extracted, revealing the narrow dimensions of the ridge

Figure 13: The facial view of the defect revealed vertical alveolar loss in conjunction with the horizontal defect seen in Figure 12


TECHNOLOGY

Figure 14: RegenerOss Allograft Putty was adapted to the ridge before being covered with a resorbable collagen membrane Figure 15: Re-entry after 6 months demonstrated

excellent bone regeneration and an increase in both the vertical and horizontal ridge dimensions Figure 16: Histology revealed vital bone cells in

conjunction with notable woven bone

exposed threads completely (Figure 9), and a biologic membrane was trimmed to fit the contours of the graft site and placed in position (Figure 10). Passive primary closure was obtained by means of periosteal releasing incisions. Primary closure was maintained throughout the healing period. Five months after implant placement, a radiograph indicated successful osteointegration. One month later, re-entry for healing abutment connection revealed that the previously exposed threads were completely encased in newly regenerated bone (Figure 11).

Case No. 3The 44-year-old male patient presented with a failing three-unit anterior maxillary bridge that had been fabricated 15 years earlier. Examination revealed that the right central incisor structure was inadequate to support a replacement restoration. The left central incisor site, a long-standing pontic, was an atrophic knife-edge ridge. The left lateral incisor presented with severe periodontal involvement, vertical loss of attachment, and mesial-buccal loss of all facial plate to the apex. After the patient began antibiotic treatment, a papillary-preserving releasing incision was made on the mesial of the right lateral incisor, extending to the left cuspid. A full-thickness flap was reflected, and the right central incisor and left lateral incisor were extracted, revealing a loss of horizontal and vertical bone (Figures 12 and 13). RegenerOss Allograft Putty was adapted to the ridge (Figure 14), and a re-sorbable cross-linked collagen membrane was placed on top of the putty. Periosteal releasing incisions were made to attain passive primary closure.

After 6 months of healing, papillary-preserving incisions were made, and a full-thickness flap was reflected, revealing notable regeneration of the alveolar crest (Figure 15). Two implant osteotomies were created in the two lateral incisor sites, and a 2 x 8 mm trephine core was harvested from a point midway between them for histological examination, and immediately stored in 10% neutral buffered formalin for histologic examination. The regenerated bone was judged to be Type 2-3. Two implants were placed in the lateral incisor positions, and primary stability was achieved. The implants healed unremarkably. Histologic preparation was executed in the same manner as described above. Microscopic examination of the histologic section revealed vital bone cells in conjunction with notable woven bone (Figure 16). The amount of residual graft particles noted in this sample was minimal and concentrated in the middle sections.

DiscussionThe outcome of osseous regeneration attempts has been shown to depend substantially on the defect morphology and the graft material used. In this case series, the same allograft putty was utilized in three different types of defects. When lesions are intraosseous, such as an extraction socket, proper containment of the graft material within the alveolar housing is limited only by the area of ingress to the bone, such as the socket entrance. Graft containment thus may be achieved in one of several ways. One technique utilizes a biocompatible collagen wound-dressing material over the graft material.49 This protects the graft from displacement, while at the same time

inducing blood-clot formation via platelet aggregation and wound stabilization. The collagen material also functions chemotactically to attract fibroblasts and promote wound coverage.50 If a membrane or collagen sponge is not used to contain the allograft within the defect, the surgeon should attempt to achieve primary closure to prevent displacement of the graft material. The author believes this is particularly important when using RegenerOss Allograft Putty as a grafting material, because the tactile feeling and taste of the lecithin carrier tends to prompt increased patient tongue habits that potentially could displace the material. When the graft material must be applied outside the skeletal envelope, space maintaining becomes a concern. The lecithin carrier of the RegenerOss product has some space-maintaining properties, as the successful results seen in Case Nos. 2 and 3 attest. However, in the opinion of the author, combining the putty with an osteoconductive graft material is apt to yield even more predictably superior clinical results. It should be noted that in the two cases reported here in which the regenerated bone was later entered surgically, the bone was judged to be Type 2 or 3, despite displaying excellent histologic results. The explanation for this may lie in the nature of the demineralized allograft material. Even though no statistical difference in percentages of new bone formed has been found between sites grafted with DFDBA and FDBA, significantly less residual bone has been documented at DFDBA-grafted sites. If the mineralized material takes longer to resorb, sites regenerated with it might appear to be harder while, in fact, being no more successful than sites grafted with demineralized material.


TECHNOLOGY

RefeRences

1. Schropp L, Wenzel A, Kostopoulos L, Karring T. Bone healing and soft tissue contour changes following single-tooth extractions: a clinical and radiographic 12-month prospective study. Int J Periodontics Restorative Dent. 2003;23:313-323.

2. Simon BI, Von Hagen S, Deasy MJ, Faldu M, Resnansky D. Changes in alveolar bone height and width following ridge augmentation using bone graft and membranes. J Periodontol. 2000;71:1774-1791.

3. Nevins M, Camelo M, De Paoli S, et al. A study of the fate of buccal wall of extraction sockets of teeth with prominent roots. Int. J Periodontics Restorative Dent. 2006;26:19-29.

4. Rangert B, Jemt T, Jorneus L. Forces and moments on Branemark implants. Int J Oral Maxillofac Implants. 1989;3:241-247.

5. Patterson EA, Burguete RL, Thoi MH, Johns RB. Distribution of load in an oral prosthesis system: an in vitro study. Int J Oral Maxillofac Implants. 1995;5:552-560.

6. Khraisat A, Abu-Hammad O, Dar-Odeh N, Al-Kayed AM. Abutment screw loosening and bending resistance of external hexagon implant system after lateral cyclic loading. Clin Implant Dent Relat Res. 2004;3:157-164. 7. Proussaefs P, Lozada J. The use of intraorally harvested autogenous block grafts for vertical alveolar ridge augmentation: a human study. Int J Periodontics Restorative Dent. 2005;25:351-363.

8. Misch C. Comparison of intraoral donor sites for onlay grafting prior to implant placement. Int J Oral Maxillofac Implants. 1997;12:767-776.

9. Pikos MA. Block autografts for localized ridge augmentation: part I. The posterior maxilla. Implant Dent. 1999;8:279-285.

10. Boyne P, James R. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg. 1980;38:613-616.

11. Tatum H Jr. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986;30:207-229.

12. Lazzara RJ. The sinus elevation procedure in endosseous implant therapy. Curr Opin Periodontol. 1996;3:178-183.

13. Duncan J, Westwood R. Ridge widening for the thin maxilla: a clinical report. Int J Oral Maxillofac Implants. 1997;12:224-227.

14. Scipioni A, Bruschi GB, Calesini G. The edentulous ridge expansion technique: a five-year study. Int J Periodontics Restorative Dent. 1994;14(5):451-459.

15. Mellonig JT, Nevins M. Guided bone regeneration of bone defects associated with implants: an evidence-based outcome assessment. Int J Periodontics Restorative Dent. 1995;15(2):168-185.

16. Zitzmann N, Naef R, Schärer P. Resorbable versus nonresorbable membranes in combination with Bio-Oss for guided bone regeneration [published erratum appears in: Int J Oral Maxillofac Implants. 1998;13(4):576]. Int J Oral Maxillofac Implants. 1997;12(6):844-852.

17. Dahlin C, Lekholm U, Becker W, et al. Treatment of fenestration and dehiscence bone defects around oral implants using the guided tissue regeneration technique: A prospective multicenter study. Int J Oral Maxillofac Implants. 1995;10:312-318.

18. Tolman D. Reconstructive procedures with endosseous implants in grafted bone: a review of the literature. Int J Oral Maxillofac Implants. 1995;10:275-294.

19. Block MS, Degen M. Horizontal ridge augmentation using human mineralized particulate bone: preliminary results. J Oral Maxillofac Surg. 2004;62:67-72,Suppl 2.

20. Jensen J, Reiche-Fischel O, Sindet-Pederson S. Nerve transposition and implant placement in the atrophic posterior mandibular alveolar ridge. J Oral Maxillofac Surg. 1994;52:662-668.

21. Urbani G, Lombardo G, Santi E, Consolo U. Distraction osteogenesis to achieve mandibular vertical bone regeneration: a case report. Int J Periodontics Restorative Dent. 1999;19:321-331.

22. Pikos MA. Block autografts for localized ridge augmentation: part II. The posterior mandible. Implant Dent. 2000;9:67-75.

23. Schwartz-Arad D, Levin L, Sigal L. Surgical success of intraoral autogenous block onlay grafting for alveolar ridge augmentation. Implant Dent. 2005;14:131-138.

24. Raghoebar GM, Louwerse C, Kalk WW, Vissink A. Morbidity of chin bone harvesting. Clin Oral Implants Res. 2001;12(5):503-507.

25. Clavero J, Lundgren S. Ramus or chin grafts for maxillary sinus inlay and local onlay augmentation: comparison of donor site morbidity and complications. Clin Implant Dent Relat Res. 2003;5(3):154-160.

26. Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? [published erratum appears in: Int J Oral Maxillofac Implants. 2008;23(1):56]. Int J Oral Maxillofac Implants. 2007;22(Suppl):49-70.

27. Misch CM, Misch CE, Resnik RR, Ismail YH. Reconstruction of maxillary alveolar defects with mandibular symphysis grafts for dental implants: a preliminary procedural report. Int J Oral Maxillofac Implants. 1992;7(3):360-366.

28. Raghoebar GM, Batenburg RH, Vissink A, Reintsema H. Augmentation of localized defects of the anterior maxillary ridge with autogenous bone before insertion of implants. J Oral Maxillofac Surg. 1996;4(10):1180-1186.

29. Widmark G, Andersson B, Ivanoff CH. Mandibular bone graft in the anterior maxilla for single-tooth implants. Presentation of surgical method. Int J Oral Maxillofac Surg. 1997;26(2):106-109.

30. McAllister BS, Haghighat K. Bone augmentation techniques. J Periodontol. 2007;78(3):377-396.

31. Libin BM, Ward HL, Fishman L. Decalcified, lyophilized bone allografts for use in human periodontal defects. J Periodontal. 1975;46(1):51-56.

32. Piattelli A, Scarano A, Corigliano M, Piattelli M. Comparison of bone regeneration with the use of mineralized and demineralized freeze-dried allografts: a histological and histochemical study in man. Biomaterials. 1996;17(11):1127-1131.

33. Francis J, Brunsvold M, Prewett A, Mellonig J. Clinical evaluation of an allogeneic bone matrix in the treatment of periodontal osseous defects. J Periodontol. 1995;66:1074-1079.

34. Minichetti JC, D’Amore JC, Hong AY, Cleveland DB. Human histologic analysis of mineralized bone

allograft (Puros) placement before implant surgery. J Oral Implantol. 2004;30:74-82.

35. Urist MR, Mikulski A, Boyd SD. A chemosterilized antigen-extracted autodigested alloimplant for bone banks. Arch Surg. 1975;110:416.

36. Becker W, Schenk R, Higuchi K, Lekholm U, Becker BE. Variation in bone regeneration adjacent to implants augmented with barrier membranes alone or with demineralized freeze-dried bone or autologous grafts: a study in dogs. Int J Oral Maxillofac Implants. 1995;10:143-154.

37. Smukler H, Landi L, Setayesh R. Histomorphometric evaluation of extraction sockets and deficient alveolar ridges treated with allograft and barrier membrane: a pilot study. Int J Oral Maxillofac Implants. 1999;14:407-416.

38. Parashis A, Andronikaki-Faldami A, Tsiklakis K. Comparison of 2 regenerative procedures – guided tissue regeneration and demineralized freeze-dried bone allograft – in the treatment of intrabony defects: A clinical and radiographic study. J Periodontol. 1998;69:751-758.

39. Lian JB, Gundberg CM. Osteocalcin. Biochemical consideration and clinical applications. Clin Orthop Res. 1998;226:267-291.

40. Aspenberg P, Lindqvist S. Ethene oxide and bone induction. Controversy remains. Acta Orthop Scan. 1998;69:173-176.

41. Tshamala M, Cox E, De Cock H, Goddeeris BM, Matheeuws D. Antigenicity of cortical bone allograft in dogs and effect of ethylene oxide-sterilization. Vet Immunol Immunopathol. 1999;69:47-59.

42. Shapoff CA, Bowers GM, Levy B, Mellonig JT, Yukna RA. The effect of particle size on the osteogenic activity of composite grafts of allogeneic freeze-dried bone and autogenous marrow. J Periodontol. 1980;51:625-630.

43. Schwartz Z, Somers A, Mellonig JT, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependant on donor age but not gender. J Periodontol. 1998;69:470-478.

44. Schwartz Z, Mellonig JT, Carnes DL Jr. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol. 1996;67:918-926.

45. Zhang M, Powers RM, Wolfinbarger L. Effect of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol. 1997;68:1085-1092.

46. Adkisson HD, Strauss-Schoenberger J, Gillis M, Wilkins R, Jackson M, Hruska KA. Rapid quantitative bioassay of osteoinduction. J Orthop Res. 2000;18:503-511.

47. Han B, Tang B, Nimni ME. Combined effects of phosphatidylcholine and demineralized bone matrix on bone induction. Connect Tissue Res. 2003;44:160-166.

48. Wuthier RE. Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxapatite in vitro. Calcif Tissue Res. 1975;19(3):197-210.

49. Wang H-L, Tsao YP. Histologic evaluation of socket augmentation with mineralized human allograft. Int J Periodontics Restorative Dent. 2008;28:231-237.

50. Gross J. Ridge preservation using HTR synthetic bone following tooth extraction. Gen Dent. 1995;43:364-367.

ConclusionThe results obtained in the cases presented in this short-term preliminary report indicate that DFDBA combined with a lecithin carrier can be used to successfully augment a variety of deficient alveolar sites.

Although the regenerated bone in two of the three cases was Type 2-3, histological findings confirmed the development of well-vascularized bone marrow and newly formed bone. The verification of the osteoinductivity of this allograft putty

may increase its reliability as a bone-augmentation material. However, future controlled clinical trials are recommended to confirm this. IP

PR

OD

UC

T P

RO

FILE


NuOss® XC Self Expanding bone grafting composite is a unique patent-pending

bone grafting composite comprised of 80% mineralized porous anorganic bovine bone, and 20% type I bovine collagen that allows for the successful implantation of a bone grafting material with increased control and less concern for subsequent complications. In its expanded form, the composite material provides optimal spacing for the bone grafting particulate, which allows for improved vascular access into the graft. The material is pre-formed into shapes and volumes commonly used for the filling of extraction sockets to enhance preservation of the alveolar ridge and in sinus lift procedures. Unlike traditional particulate materials, NuOss XC can be placed without hydration, in a compressed format, allowing for expansion upon contact with blood or saline. The composite nature of the material allows for precise placement of the graft, with minimal concern of particle migration. Efficiency of graft placement into the sinus cavity or extraction socket may be enhanced as well. NuOss XC requires no special handling and can be stored at room temperature. The unique composite nature of this material allows for minimal graft preparation time and graft delivery. As well, the complete binding of the particles within the collagen framework increases confidence in minimal risk of particle migration and subsequent infections. The unique self-expanding nature of the material may allow for a less invasive procedure to be utilized while still allowing an adequate amount of grafting material to be placed.

NuOss XC is the latest develop-ment in natural bone substitutes.• NuOss XC supports bone growth in

periodontal and oral maxillofacial defects.• NuOss XC is a composite grafting

material comprised of mineralized de-proteinated bovine granules and purified type I bovine collagen. When placed into a bleeding site, the material expands to a predetermined size and shape.

• NuOss XC is available in both socket and sinus forms.

• NuOss XC is easy to place, prevents particle migration, and saves time.

Features and Benefits:• Expanding composite material allows for

placement in a compressed form with self-expansion to fill the entire defect upon hydration.

• Simple implantation technique.• Composite nature of the material

enhances graft stability and minimizes particulate migration.

•Optimizes spacing between particulate to allow for bone ingrowth.

Expansion time: Immediately upon con-tact with blood source or by hydration with sterile saline after implantation.

To learn more about NuOss® XC and other bone grafting solutions offered by ACE Surgical, visit their web site at www.acesurgical.com.

This information was provided by Ace Surgical Supply.

NuOss® XC bone grafting composite

IP

NuOss® XC Socket

NuOss® XC Sinus

In the ever-changing world of implant dentistry, we are finding ourselves in a

battle with our patients over the amount of time needed to provide their care. With national ad campaigns discussing teeth in an hour and teeth in a day, we often find ourselves backed into a corner in respect to time and credibility. When our patients ask questions regarding TV or print advertisements, they are really trying to find out if we do those procedures. We usually try to answer them in an educated manner based on proper clinical techniques and evidence-based dentistry; however, patients perceive anything contrary to the advertisement as an excuse. We must strive to be proactive with our own treatment plans particularly in the field of immediately loaded dental implants. I recently mentored a live surgery at the Rocky Mountain Dental Institute where this was indeed the case. The doctor treatment planned an immediately loaded lower denture case using BioHorizons’ TeethXpress™ protocol. The problem was not with the procedure but in the expectation of the final product. The immediately converted denture is not the definitive restoration but merely a transitional appliance on the way to the final prosthesis. The ultimate final prosthesis is based on many variables such as a screw-retained denture, a locator-retained denture or any number of full fixed appliances. These choices come with different price tags as well as different treatment time frames. This case was treatment planned for six dental implants using Tx STUDIO™ and

a CBCT from the i-CAT® FLX (Imaging Sciences International) machine. A duplicate denture was fabricated to use as a surgical guide for implant placement and positioning and six BioHorizons’ Laser-Lok Tapered dental implants were placed, and the anterior four implants were used to convert the denture chairside following the TeethXpress protocol. The simplicity and quality of the BioHorizons’ multiunit abutment makes these kinds of cases very predictable. The doctor’s plan is for

4 months of integration prior to fabrication of the final restoration, which is treatment planned for a screw-retained full fixed prosthesis. This resulted in a wonderful treatment for the patient and an even better experience for the dentist. By avoiding the excuses and being proactive with patient education, we can win this battle. I will part with a quote from one of my mentors, Dr. John Kois, “Dentists should not be viewed as the hitman, but rather as the healer.”

I want my teeth yesterday!


ON THE HORIZON

Dr. Justin Moody discusses a time saving technology in a fast paced world

Figure 2: Placement of the multiunit abutment

Figure 3: Titanium pickup copings

Figure 1: Duplicated denture used as surgical guide

Dr. Justin Moody is a Diplomate with the American Board of Oral Implantology and with the International Congress of Oral Implantologists, Fellow and Associate Fellow of the American Academy of Implant Dentistry, Adjunct Professor at the University of Nebraska Medical College, and Founder and Director of the Rocky Mountain Dental Institute. He is an international speaker and is in private practice at The Dental Implant Center in Rapid City, South Dakota. He can be reached at [email protected] or at drjustinmoody.com.

Figure 4: Lower denture conversion

Figure 5: Final i-CAT pano

IP

Implant Practice US is a peer-reviewed, bimonthly publication containing articles by leading authors from around the world. Implant Practice US is designed to be read by specialists in Periodontics, Oral Surgery, and Prosthodontics.

Submitting articlesImplant Practice US requires original, unpublished article submissions on implant topics, multidisciplinary dentistry, clinical cases, practice management, technology, clinical updates, literature reviews, and continuing education. Typically, clinical articles and case studies range between 1,500 and 3,000 words. Authors can include up to 15 illustrations. Manuscripts should be double-spaced, and all pages should be numbered. Implant Practice US reserves the right to edit articles for clarity and style as well as for the limitations of space available. Articles are classified as either clinical, continuing education, technology, or research reports. Clinical articles and continuing education articles typically include case presentations, technique reports, or literature reviews on a clinical topic. Research reports state the problem and the objective, describe the materials and methods (so they can be duplicated and their validity judged), report the results accurately and concisely, provide discussion of the findings, and offer conclusions that can be drawn from the research. Under a separate heading, research reports provide a statement of the research’s clinical implications and relevance to implant dentistry. Clinical and continuing education articles include an abstract of up to 250 words. Continuing education articles also include three to four educational aims and objectives, a short “expected outcomes” paragraph, and a 10-question, multiple-choice quiz with the correct answers indicated. Questions and answers should be in the order of appearance in the text, and verbatim. Product trade names cited in the text must be accompanied by a generic term and include the manufacturer, city, and country in parentheses.

Additional items to include:• Include full name, academic degrees, and

institutional affiliations and locations • Ifpresentedaspartofameeting,pleasestate

the name, date, and location of the meeting• Sources of support in the form of grants,

equipment, products, or drugs must be disclosed

• Fullcontactdetailsforthecorrespondingauthormust be included

• Shortauthorbio• Authorheadshot

Pictures/imagesIllustrationsshouldbeclearlyidentified,numberedin sequential order, and accompanied by a caption. Digital images must be high resolution, 300 dpi minimum, and at least 90 mm wide. We can accept digital images in all image formats (preferring .tif or jpeg).

TablesEnsure that each table is cited in the text. Number tables consecutively and provide a brief title and caption (if appropriate) for each.

ReferencesReferences must appear in the text as numbered superscripts (not footnotes) and should be listed at the end of the article in their order of appearance in the text. The majority of references should be less than 10 years old. Provide inclusive page numbers, volume and issue numbers, date of publication, and all authors’ names. References should be submitted in American Medical Association style. Forexample:

Journals:(Print)Greenwall L. Combining bleaching techniques. Aesthetic & Implant Dentistry. 2000;1(1):92-96.(Online)Author(s). Article title. Journal Name. Year;vol(issue#):inclusive pages. URL. Accessed[date].

Or in the case of a Book:Greenwall L. Bleaching techniques in Restorative Dentistry: An Illustrated Guide. London: MartinDunitz; 2001.

Website:Author or name of organization if no author is listed. Title or name of the organization if no title is provided. Name of website. URL. Accessed Month Day,Year. Example ofDate:Accessed June12,2011.

Author’s name: (Single) (Multiple) DoeJF DoeJF,RoeJP

PermissionsWritten permission must be obtained by the author for material that has been published in copyrighted material; this includes tables, figures, pictures, and quoted text that exceeds 150 words. Signed release forms are required for photographs of identifiable persons.

Disclosure of financial interestAuthors must disclose any financial interest they (or family members) have in products mentioned in their articles. They must also disclose any developmental or research relationships with companies that manufacture products by signing a“Conflictof InterestDeclaration” formaftertheirarticle is accepted. Any commercial or financial interest will be acknowledged in the article.

Manuscript ReviewAll clinical and continuing education manuscripts are peer reviewed and accepted, accepted with modification, or rejected at the discretion of the editorial review board. Authors are responsible for meeting review board requirements for final approval and publication of manuscripts.

ProofingPage proofs will be supplied to authors for corrections and/or final sign off. Changes should be limited to those that are essential for correctness and clarity.

Articles should be submitted to:MaliSchantz-Feld,[email protected]

Reprints/Extra issuesIf reprints or additional issues are desired, theymust be ordered from the publisher when the page proofs are reviewed by the authors. The publisher does not stock reprints; however, back issues can be purchased.


AUTHOR GUIDELINES

Checklist for article submissions:

3 A copy of the manuscript and figures/captions, including all pictures (low res) necessary for reviewers

3 Manuscript:double-spacedincludingseparate references, figure legends, and tables

3 Abstract, educational objectives, expected outcomes paragraph

3 References:double-spaced,alphabetical,American Medical Association style

3 Tables:titledandcitedinthetext

3 Mandatory submission form, signed by all authors

Please contact managing editor Mali Schantz-Feldwithanyquestionsviaemail:[email protected]

800/448 8168www.straumann.us

More than a supplier. A partner for life.

M A T E R I A L S&

E Q U I P M E N Tlllllllllllll lllllllllllll


BIOMET 3i™ T3® Tapered Implant System

The BIOMET 3i™ T3® Tapered Implant System has been engineered to provide: * The primary stability necessary for early

esthetic provisional restoration and/or tissue sculpting.

* A refined surface design to enhance osseointegration, with no increased risk of peri-implantitis and compared to hybrid implants.

* The system strength for long-term esthetic function.

* An implant/abutment geometry and related connection features designed to preserve bone at and around the implant to provide support for the development and maintenance of soft tissue.

* Highly accurate connection well-positioned to meet current and future digital restorative needs.

For more information, visit: biomet3i.com.

Osteocel® allograft cellular bone matrix product retaining MSCs and osteoprogenitors

The proprietary processing technology that produces Osteocel results in a viable bone matrix product that preserves the native MSCs and osteoprogenitors found in marrow-rich bone. It was the first product available to have the desired beneficial properties of autograft — osteoconduction, osteoinduction, and osteogenesis — and that allows surgeons to provide their patients with a complete solution without the added risk and cost of a secondary procedure.

For more information, visit Ace Surgical at www.acesurgical.com.

Implant planning with Anatomage

Full resolution –— no compromiseAnatomage can utilize full-resolution DICOM data very easily for both 3D volume renderings and 2D cross sections. When placing implants, a fraction of a millimeter can make the different between success and failure, and Anatomage gives you ability to plan with the highest level of accuracy for clinical success and patient safety.

Fast planningAnatomage offers the fastest workflow for implant planning — so fast, it can be done chairside in front of the patient for the most exciting patient presentations. After opening the DICOM data directly from the CBCT machine, implants can be placed immediately, with no waiting for file conversions, no model making, no issues with noise having to be cut out, and no confusing navigation or software interfaces.

Restoration-based implant planning Anatomage supports both crown-down and implant-up treatment planning methods by combining other types of clinical data with the CT scan, such as a laser scan of the stone models or an intraoral scan of the dentition. Virtual wax-ups can be incorporated as well. Furthermore, these advanced options are exclusively tied in with our surgical guide service to complete the circle of virtual planning to clinical treatment.

No conversionAnatomage has completely done away with the file conversion step of implant planning by allowing you to start with your own DICOM file and place implants immediately.

Visual simulationsAnatomage software has multiple simulation creation tools as options for the most cutting-edge case presentation potential.

Guided surgery With Anatomage’s very own surgical guide, your virtual treatment plan can become a real device that can be used to accomplish your treatment exactly as planned.

For more information, visit Anatomage at www.anatomage.com.

Innovative Imprint™ 4 VPS Impression Material WIth innovative advancements in material sciences, Imprint 4 VPS Impression Material cuts intraoral setting time nearly in half of its predecessor, Imprint 3 VPS Impression Material, and other leading competitive VPS dental impression materials. You can noticeably reduce chair time and stress for patients — without reducing the precision of your impression result. Imprint 4 material offers the fastest intraoral stewing time among leading VPS fast-setting impression materials.

For more information, visit 3M ESPE at: http://solutions.3m.com/wps/portal/3M/en_US/3M-ESPE-NA/dental-professionals/

Announcing DEXIS Mac

S-4000 Quantum Light

Standard Features of the S-4000 Quantum Light include:• VariableLightIntensityfrom650f.c.to2800f.c.

@ 24”.•Motionsensoron/off.• FlexArmprovides53”ofhorizontalreachand

27” of vertical adjustment.•OpticsfeaturefourLEDlightsratedfor50,000hours.• Colortemperatureis5500-6500degreesK.• Lightfieldis2.75”x7”@focallengthof24”.• Lightheadhas3axisadjustability.• Handleisremovableandautoclavable. For more information, visit: www.boydindustries.com.

New coating, Ti Golden®, improves esthetics and biological interface BTI Biotechnology Institute’s R&D Department has developed a new and efficient solution: The Ti Golden® coating that converts titanium into a material with a number of advantages.

Golden finish: The golden color of these prosthetic attachments with the Ti Golden® layer achieves a better esthetic, which is highly significant in transmitting greater warmth to the gingival tissues.

At gingival level: Improved union between the hemidesmosones and the new surface, improving the biological seal.

Improves the antimicrobial properties: The bacterial colonization decreases, therefore minimizing the risk of peri-implantitis.

See more at: http://bti-biotechnologyinstitute.com/us/latest-news/product-news/new-proscetic-components-tigolden-tiblack/#sthash.pCvMxLq8.dpuf.

For more information, visit: bti-biotechnologyinstitute.com/us.


ASA DENTAL ASA Dental, manufacturer of dental instruments, proudly announces the launch of AsaFresh, a new line of mint-scented saliva ejectors. With its cool mint scent, AsaFresh provides a pleasant feeling of mouth freshness and helps patients relax throughout the duration of the visit. AsaFresh is patented by Asa Dental.

For more information, visit: www.asadental.com/index.asp.

DEXIS, an industry leader and the manufacturer of the highly awarded DEXIS® Digital X-ray system, is now in the process of completing its development for the Mac platform and will soon be expanding its Imaging Suite of products to natively support Apple® hardware and the OSXoperatingsystem10.8.0andabove.DEXISMac™ is an innovative dental imaging solution that offers dentists a unified experience across Mac and iOS products. Once released, the native OS X software will provide clinicians with a highly efficient digital imaging workflow and seamless integration with Mac-based practice management programs Viive™ and MacPractice®. This DEXIS software product will provide an intuitive user interface and advanced functionality that Mac users expect — combined with tried-and-true DEXIS image management and enhancement tools, as well as a tight integration with the award-winning DEXIS go® app for patient communication, and the just released DEXIS photo™ app for extra-oral image acquisition.

For more information, visit: www.dexis.com.

CEAesthetics Through Innovation - Clinical Expertise Evening Seminars January 21, 2014 – Montreal, CanadaJanuary 22, 2014 – Toronto, CanadaJanuary 28, 2014 – Bethesda, MDJanuary 29, 2014 – Los Angeles, CAFebruary 6, 2014 – San Francisco, CAwww.iird.com/education.html

Navigating Today’s Clinical Challenges Pam Hughes, RDH, MS February 1, 2014 Las Vegas, NV sdm.unlv.edu/ce

Risk Management Strategies to Reduce Dental LiabilityDr. Michael ReganFebruary 15, 2014 Las Vegas, NV sdm.unlv.edu/ce

The Role of the Implant Treatment Coordinator: From Office Infrastructure to Referral and Patient Management February 7, 2014 Palm Beach Gardens, FL 1-800-717-4143inside.3iimplant.com/global_pro_ed/pdf/MKT833%20020714%20Collins%20ITC%20Flyer.pdf

Implantology Course 1- Hands-on Dental Implant Placement Training CE and Bone Grafting Seminars January 31 - February 1, 2014March 7 - 8, 2014Burbank, CA 1-888-393-6355implantologyseminars.com

WEBINARS Diagnosis and Treatment Planning in the Esthetic Zone - Part Iimplanteducation.net

Diagnosis and Treatment Planning in the Esthetic Zone - Part IIimplanteducation.net

Graft-less Solutions in Implant Dentistryimplanteducation.net

FREE WEBINARS Are Diode Lasers Worth the Investment?Todd Snyder, DDSwww.amdlasers.com

The AMD LASERS’ Picasso is THE soft tissue hand-piece and is an essential part of dental practice for the dentist and the hygienistDr. Edward Lynchwww.amdlasers.com

The role of the diode laser in restorative cosmetic dentistryDr. Glenn van Aswww.amdlasers.com

An introduction to diode lasers: Top 10 procedures you can do with your diode laserDr. Glenn van Aswww.amdlasers.com

An open panel discussion on laser dentistryDr. Fay Goldstep and Dr. George Freedmanwww.amdlasers.com

EvENTSComprehensive Implant Residency Program 6 (CIRP) Dr. Michael McCracken January 23-25, 2014 Birmingham, AL www.biohorizons.com

Hybridge Education Seminar: Level Training January 23-25, 2014 Rochester, NY www.biohorizons.com

Georgia Academy of Cosmetic Dentistry Dr. John C. Kois January 24, 2014 Atlanta, GA www.biohorizons.com

The 39th Annual USC International Periodontal and Implant Symposium January 24, 2014 Los Angeles, CA www.biohorizons.com

Michigan Periodontal Association 2014 Annual Meeting Dr. Marc Nevins January 25, 2014 Novi, MI www.biohorizons.com

Washington State Society of Oral and Maxillofacial Surgeons (WSSOMS) January 28, 2014 Bellevue, WA www.biohorizons.com

Rocky Mountain Dental Institute: Grafting - Hard and Soft Tissue as well as SinusDr. Lewis Cummings January 30, 2014 Denver, CO www.biohorizons.com

Southwest Dental Conference 87th Annual Meeting January 30 - February 1, 2014 Dallas, TX www.biohorizons.com

Yankee Dental Congress January 30 - February 1, 2014 Boston, MA www.biohorizons.com

Pikos Implant Institute: Extraction Site ManagementDr. Mike Pikos January 31 - February 1, 2014 Trinity, FL /www.biohorizons.com

CDS Midwinter MeetingMcCormick Place West Building February 20 - 22, 2014 Chicago, IL www.bicon.com/index.htm

DIARYOF EVENTSlllllllllllllllllllllll llllllllllllllllllllllllllllllllllllllllllllllllllll


A Legacy of Innovation

www.implantdirect.com | 888-649-6425

Legacy™4 ImplantNew

All-in-1 Packaging includes implant, fixture-mount, abutment, transfer, cover screw & healing collar — $225 SBM, $250 HA surface

A Legacy of Innovation from Dr. Gerald NiznickLegacy 4 – the culmination of 30 years of evolutionIntroducing a revolutionary 2-piece fixture-mount/abutment that provides the accuracy of an open-tray transfer with the simplicity of a closed-tray transfer.

Our price

StraightContoured

LaboratoryAbutment

15° AngledContoured

StraightSnap-On

Gold/Plastic

Zirconia/TiAbutment

PlasticTemporaryAbutment

Ball Attachment

GPS™ Attachment AngledStraight

$100$85 $100$100 $120 $120 $40 $112 $100 $100 $120$120

Multiple-Unit w/Cap & Transfer

AngledGPS™

Attachment

Square top detaches with the impression, providing a snap attachment for abutment/analog.

Square top detaches with impression formetal to metal

transfer accuracy

Torque- safetyfeature prevents damage

to implant interface

Progressively deeperbuttress threads

Quadruple-leadmicro-threads

Concave transgingival profilematched with healing collar to shape

soft tissue for improved esthetics

Two-Piece fixture-mount (patent pending) with

preparable abutment

Three long cutting grooves

The abutment portion of the fixture-mount snaps onto thetransferred top for the accuracy of a metal-to-metal connection

implant practice us - january/february 2014 issue - vol7.1

Documents

norton bds

lds rcs

msc gareth jenkins bds

msc paul tipton bds

alexandra day bds

mgds rcs christopher

fds rcs philip freiburger

mfds rcs